Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	SH3 domain binding	PTPN22 FMN1 DNM1 SHANK1 ESPN BCAR1 SHANK3 ARHGAP6 KHDRBS1 ERRFI1 SOS1	3.78e-07	143	212	11	GO:0017124
GeneOntologyMolecularFunction	protein domain specific binding	ADGRB1 DAG1 IRF3 PTPN22 KCNH2 FMN1 DNM1 SHANK1 ESPN CARD19 KIF21A TACC2 BCAR1 SHANK3 THAP7 ARHGAP6 L3MBTL1 KHDRBS1 ERRFI1 TNK2 TNKS1BP1 IRS2 RIMS2 SRRM2 SOS1	6.88e-06	875	212	25	GO:0019904
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DENND2A GBF1 ARHGAP30 DENND2B RIN2 STXBP5L RALGAPB PLEKHG2 RGS3 TBC1D17 ARHGAP6 ARHGEF40 ARAP3 ERRFI1 GPSM3 TNK2 SOS1	3.13e-05	507	212	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DENND2A GBF1 ARHGAP30 DENND2B RIN2 STXBP5L RALGAPB PLEKHG2 RGS3 TBC1D17 ARHGAP6 ARHGEF40 ARAP3 ERRFI1 GPSM3 TNK2 SOS1	3.13e-05	507	212	17	GO:0030695
GeneOntologyMolecularFunction	ankyrin repeat binding	SHANK1 KIF21A TNKS1BP1	4.00e-05	7	212	3	GO:0071532
GeneOntologyMolecularFunction	actin binding	XIRP1 MAP1A SYNPO2L DAG1 SPATA31C1 FMN1 SYN1 WIPF2 ESPN ABI3BP SPATA32 SHANK3 XIRP2 MYO15A CTTN	1.95e-04	479	212	15	GO:0003779
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	IRF2BP2 MAP1A PPRC1 BCORL1 RB1CC1 TSC22D1 FBXO42 MSL3 TRIM8 SYN1 NOTCH1 ZNF541 PML SHANK1 DDX17 AMBRA1 DOK2 SHANK3 THAP7 NCOR2 KMT2D KHDRBS1 IRS2 RIMS2 SPEN SOS1	2.59e-04	1160	212	26	GO:0030674
GeneOntologyMolecularFunction	protein kinase binding	CYLD PTPN22 RB1CC1 STK11IP TRIM8 SYN1 PRKAG2 DNM1 DOK2 BCAR1 GRM5 TESK1 ZFP36 PITPNM1 KHDRBS1 CDK13 ERRFI1 PITPNM3 DNM3 AKAP11 IRS2	4.19e-04	873	212	21	GO:0019901
GeneOntologyMolecularFunction	synaptic receptor adaptor activity	SHANK1 SHANK3	6.64e-04	4	212	2	GO:0030160
GeneOntologyMolecularFunction	GTPase activator activity	ARHGAP30 RIN2 STXBP5L RALGAPB RGS3 TBC1D17 ARHGAP6 ARAP3 ERRFI1 SOS1	8.30e-04	279	212	10	GO:0005096
GeneOntologyMolecularFunction	structural constituent of synapse	SHANK1 SHANK3 DNM3 RIMS2	1.01e-03	42	212	4	GO:0098918
GeneOntologyMolecularFunction	protein tyrosine kinase binding	PTPN22 DOK2 GRM5 PITPNM1 KHDRBS1 PITPNM3 IRS2	1.08e-03	149	212	7	GO:1990782
GeneOntologyMolecularFunction	molecular adaptor activity	IRF2BP2 MAP1A PPRC1 BCORL1 RB1CC1 TSC22D1 FBXO42 MSL3 TRIM8 SYN1 PLCB3 NOTCH1 ZNF541 PML SHANK1 DDX17 AMBRA1 DOK2 SHANK3 THAP7 NCOR2 KMT2D KHDRBS1 IRS2 RIMS2 SPEN SOS1	1.20e-03	1356	212	27	GO:0060090
GeneOntologyMolecularFunction	proline-rich region binding	CYLD GAREM1 CTTN	1.36e-03	21	212	3	GO:0070064
Domain	SAM_DOMAIN	CASKIN2 GAREM1 SHANK1 SHANK3 SCML4 ARAP3 L3MBTL1	1.01e-04	95	211	7	PS50105
Domain	SAM	CASKIN2 GAREM1 SHANK1 SHANK3 SCML4 ARAP3 L3MBTL1	1.16e-04	97	211	7	IPR001660
Domain	SAM_1	CASKIN2 GAREM1 SHANK1 SHANK3 SCML4 L3MBTL1	1.18e-04	68	211	6	PF00536
Domain	Actin-binding_Xin_repeat	XIRP1 XIRP2	1.27e-04	2	211	2	IPR012510
Domain	GTPase_binding	ERRFI1 TNK2	1.27e-04	2	211	2	PF09027
Domain	Inhibitor_Mig-6	ERRFI1 TNK2	1.27e-04	2	211	2	PF11555
Domain	XIRP1/XIRP2	XIRP1 XIRP2	1.27e-04	2	211	2	IPR030072
Domain	XIN	XIRP1 XIRP2	1.27e-04	2	211	2	PS51389
Domain	Xin	XIRP1 XIRP2	1.27e-04	2	211	2	PF08043
Domain	Mig-6	ERRFI1 TNK2	1.27e-04	2	211	2	IPR021619
Domain	Cdc42_binding_dom-like	ERRFI1 TNK2	1.27e-04	2	211	2	IPR015116
Domain	PDZ	SYNPO2L PDZD7 MAST4 SHANK1 HTRA2 RGS3 SHANK3 RIMS2	2.04e-04	141	211	8	PF00595
Domain	PDZ	SYNPO2L PDZD7 MAST4 SHANK1 HTRA2 RGS3 SHANK3 RIMS2	2.83e-04	148	211	8	SM00228
Domain	-	SYNPO2L PDZD7 MAST4 SHANK1 HTRA2 RGS3 SHANK3 RIMS2	3.10e-04	150	211	8	2.30.42.10
Domain	PDZ	SYNPO2L PDZD7 MAST4 SHANK1 HTRA2 RGS3 SHANK3 RIMS2	3.24e-04	151	211	8	PS50106
Domain	PDZ	SYNPO2L PDZD7 MAST4 SHANK1 HTRA2 RGS3 SHANK3 RIMS2	3.39e-04	152	211	8	IPR001478
Domain	SAM/pointed	CASKIN2 GAREM1 SHANK1 SHANK3 SCML4 ARAP3 L3MBTL1	3.69e-04	117	211	7	IPR013761
Domain	Elf-1_N	ELF1 ELF4	3.78e-04	3	211	2	PF12310
Domain	TF_Elf_N	ELF1 ELF4	3.78e-04	3	211	2	IPR022084
Domain	NPIP	NPIPB3 NPIPB5 NPIPB13	4.72e-04	14	211	3	IPR009443
Domain	SAM	CASKIN2 SHANK1 SHANK3 SCML4 ARAP3 L3MBTL1	4.86e-04	88	211	6	SM00454
Domain	FERM_f0	SHANK1 SHANK3	7.51e-04	4	211	2	PF16511
Domain	FERM_f0	SHANK1 SHANK3	7.51e-04	4	211	2	IPR032425
Domain	PH	DNM1 PLEKHA7 DOK2 PLEKHG2 PLEKHA6 ARAP3 DNM3 IRS2 SOS1	1.21e-03	229	211	9	PF00169
Domain	FYrich_C	KMT2A KMT2D	1.24e-03	5	211	2	IPR003889
Domain	FYrich_N	KMT2A KMT2D	1.24e-03	5	211	2	IPR003888
Domain	FYRC	KMT2A KMT2D	1.24e-03	5	211	2	SM00542
Domain	FYRN	KMT2A KMT2D	1.24e-03	5	211	2	SM00541
Domain	FYRN	KMT2A KMT2D	1.24e-03	5	211	2	PF05964
Domain	FYRC	KMT2A KMT2D	1.24e-03	5	211	2	PF05965
Domain	FYRC	KMT2A KMT2D	1.24e-03	5	211	2	PS51543
Domain	FYRN	KMT2A KMT2D	1.24e-03	5	211	2	PS51542
Domain	PH	DNM1 PLEKHA7 DOK2 PLEKHG2 PLEKHA6 ARHGEF40 ARAP3 DNM3 IRS2 SOS1	1.28e-03	278	211	10	SM00233
Domain	-	CASKIN2 SHANK1 SHANK3 SCML4 ARAP3 L3MBTL1	1.29e-03	106	211	6	1.10.150.50
Domain	PH_DOMAIN	DNM1 PLEKHA7 DOK2 PLEKHG2 PLEKHA6 ARHGEF40 ARAP3 DNM3 IRS2 SOS1	1.32e-03	279	211	10	PS50003
Domain	PH_domain	DNM1 PLEKHA7 DOK2 PLEKHG2 PLEKHA6 ARHGEF40 ARAP3 DNM3 IRS2 SOS1	1.35e-03	280	211	10	IPR001849
Domain	-	PLCB3 DNM1 PLEKHA7 DOK2 PLEKHG2 PLEKHA6 RGS3 ARHGEF40 ARAP3 DNM3 IRS2 SOS1	1.70e-03	391	211	12	2.30.29.30
Domain	Dynamin_central	DNM1 DNM3	1.85e-03	6	211	2	IPR000375
Domain	LNS2	PITPNM1 PITPNM3	1.85e-03	6	211	2	IPR013209
Domain	GED	DNM1 DNM3	1.85e-03	6	211	2	SM00302
Domain	PI_transfer	PITPNM1 PITPNM3	1.85e-03	6	211	2	IPR001666
Domain	LNS2	PITPNM1 PITPNM3	1.85e-03	6	211	2	SM00775
Domain	DDHD	PITPNM1 PITPNM3	1.85e-03	6	211	2	PF02862
Domain	DDHD	PITPNM1 PITPNM3	1.85e-03	6	211	2	PS51043
Domain	DDHD_dom	PITPNM1 PITPNM3	1.85e-03	6	211	2	IPR004177
Domain	Dynamin_M	DNM1 DNM3	1.85e-03	6	211	2	PF01031
Domain	GED_dom	DNM1 DNM3	1.85e-03	6	211	2	IPR020850
Domain	Haem_d1	KMT2A STXBP5L	1.85e-03	6	211	2	IPR011048
Domain	LNS2	PITPNM1 PITPNM3	1.85e-03	6	211	2	PF08235
Domain	GED	DNM1 DNM3	1.85e-03	6	211	2	PS51388
Domain	LNS2/PITP	PITPNM1 PITPNM3	1.85e-03	6	211	2	IPR031315
Domain	Dynamin_GTPase_CS	DNM1 DNM3	1.85e-03	6	211	2	IPR019762
Domain	GED	DNM1 DNM3	1.85e-03	6	211	2	PF02212
Domain	GED	DNM1 DNM3	1.85e-03	6	211	2	IPR003130
Domain	DDHD	PITPNM1 PITPNM3	1.85e-03	6	211	2	SM01127
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	GBF1 ACACB MAP1A APC2 PTPN22 ZNF469 PRR14 MGA PLEKHA7 SAP130 NOTCH1 GAREM1 CRTC3 CUX2 WEE1 SCAMP3 BCAR1 POM121C ARHGAP6 NCOR2 AATK XIRP2 EIF4EBP1 TNK2 SPEN SOS1	7.81e-18	430	223	26	35044719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	GBF1 PPRC1 THAP8 STK11IP CASZ1 EPS15L1 ZBED4 ZFP36L2 KCNH2 MCM3AP IFRD2 MLLT1 CRAMP1 NOTCH1 GAREM1 FAM193B AMBRA1 POM121C TESK1 TBC1D17 MICALL1 HIVEP3 NCOR2 ARHGEF40 KMT2D AATK ARAP3 CELSR3 CDK13 ANKRD11 TNK2 PCNX1 TNKS1BP1 IRS2 LTK SPEN ALKBH6 IL4R	2.68e-17	1105	223	38	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L IRF2BP2 SRRM1 CHAF1B GBF1 CARHSP1 EPS15L1 MSL3 KMT2A PLCB3 HOMEZ WEE1 RALGAPB USP24 MICALL1 PITPNM1 NCOR2 KMT2D CDK13 ELF1 TNKS1BP1 IRS2 CTTN SRRM2 SPEN KLHDC4 SOS1	1.14e-12	774	223	27	15302935
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD ATXN2L SRRM1 NES GBF1 DENND2B MAST4 ZFP36L2 CASKIN2 PRRC2C KMT2A PLEKHA7 PML DYRK2 CRTC3 WEE1 RALGAPB PLEKHG2 BCAR1 RAB11FIP1 TESK1 MICALL1 ANKRD11 AKAP11 TNKS1BP1 IRS2 SRRM2 OTOG	2.25e-12	861	223	28	36931259
Pubmed	A census of human transcription factors: function, expression and evolution.	CARHSP1 THAP8 IRF3 TSC22D1 ZBED4 ZFP36L2 NFIB KMT2A MLLT1 PLAGL2 DLX3 MGA CRAMP1 ZNF541 HOMEZ RC3H2 CUX2 NR1H3 RFX2 THAP7 HIVEP3 BCL6B FOXB1 KMT2D ZFHX4 ELF1 ELF4 ELK4	7.88e-12	908	223	28	19274049
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	IRF2BP2 SRRM1 DAG1 CASKIN2 DNM1 WIPF2 DDX17 MICALL1 KHDRBS1 SRRM2	2.15e-09	108	223	10	19531213
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ATXN2L SRRM1 CARHSP1 EPS15L1 DDX17 USP24 TACC2 PLEKHA6 BCAR1 RAB11FIP1 CDK13 ELF1 TNKS1BP1 TMEM131 IRS2 CTTN SRRM2 SPEN	5.33e-09	503	223	18	16964243
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DENND2A NRXN3 MAST4 CASKIN2 PLAGL2 FAM149B1 CRAMP1 HOMEZ USP36 KIF21A UVSSA AMBRA1 MICALL1 CELSR3 PCNX1 AKAP11 TNKS1BP1 RIMS2	1.16e-08	529	223	18	14621295
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	ATXN2L SRRM1 ARHGAP30 EPS15L1 USP24 SCAMP3 DOK2 CDK13 CTTN SRRM2	1.63e-08	133	223	10	15144186
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD SRRM1 CHAF1B ZNF219 MAP1A TNRC6B ZNF469 MCM3AP WDR20 MLLT1 MGA SAP130 PML USP36 WEE1 AMBRA1 RAB11FIP1 POM121C NCOR2 ARHGEF40 ZFHX4 IRS2 LTK SRRM2 UNC80 SOS1	1.64e-08	1116	223	26	31753913
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	EPS15L1 DNM1 WIPF2 GAREM1 KHDRBS1 ERRFI1 DNM3 IRS2 SOS1	2.32e-08	103	223	9	21706016
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CYLD GBF1 TNRC6B SMC5 CUX2 RALGAPB AATK DNM3 PCNX1 AKAP11 TNKS1BP1 UNC80	2.82e-08	225	223	12	12168954
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATXN2L SRRM1 MAP1A EPS15L1 SYN1 STXBP5L PLEKHA6 PITPNM1 PITPNM3 TNKS1BP1 CTTN RIMS2 SRRM2 SOS1	6.50e-08	347	223	14	17114649
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SRRM1 GBF1 CARHSP1 PTPN22 FCHO1 PRRC2C USP36 CELSR3 KHDRBS1 ZFHX4 CDK13 IRS2 SRRM2 SPEN	1.06e-07	361	223	14	26167880
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ACACB DAG1 NFIB MCM3AP PLEKHA7 NOTCH1 CRTC3 POM121C NCOR2 KHDRBS1	2.83e-07	180	223	10	35198878
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SRRM1 CHAF1B ZNF219 BCORL1 CASZ1 ZBED4 NFIB MSL3 KMT2A MLLT1 MGA SAP130 TET3 HOMEZ USP36 DDX17 NOL9 POM121C NCOR2 KMT2D KHDRBS1 CDK13 ANKRD11 ELF4 SRRM2 SPEN	2.96e-07	1294	223	26	30804502
Pubmed	Interaction network of human early embryonic transcription factors.	ACACB BCORL1 NFIB MCM3AP KMT2A MGA HOMEZ SCAMP3 POM121C NCOR2 KMT2D ZFHX4 SPEN	5.12e-07	351	223	13	38297188
Pubmed	A human MAP kinase interactome.	MAP1A TSC22D1 MCM3AP MGA WIPF2 GAREM1 SHANK1 CRTC3 ABI3BP PLEKHA6 POM121C KHDRBS1 ERRFI1 TNK2 SOS1	6.82e-07	486	223	15	20936779
Pubmed	PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.	CYLD TNRC6B EPS15L1 PRRC2C AMOTL1 TNKS1BP1	7.22e-07	49	223	6	31762063
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GBF1 FCHO1 CASZ1 TSC22D1 FBXO42 MGA FAM193B CC2D1B PLEKHA6 POM121C SHANK3 HIVEP3 CDK13 POM121B UNC80	8.16e-07	493	223	15	15368895
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	IRF2BP2 ZNF219 ACACB BCORL1 CASZ1 NFIB TRIM8 WEE1 USP24 POM121C SEC31B NCOR2 KMT2D PITPNM3 IRS2 H2BC19P SPEN	9.32e-07	638	223	17	31182584
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L SRRM1 BCORL1 SMC5 EPS15L1 NUTM2B PRRC2C KMT2A MLLT1 MGA SAP130 PML USP36 TCEA2 DDX17 NCOR2 KHDRBS1 ANKRD11 CTTN SRRM2 SPEN	1.06e-06	954	223	21	36373674
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	IRF2BP2 ADM2 ZBED4 PRRC2C AMOTL1 WDR20 PLAGL2 RC3H2 DDX17 BCAR1 ANKRD11 TNKS1BP1	1.82e-06	332	223	12	37433992
Pubmed	Human transcription factor protein interaction networks.	CYLD IRF2BP2 ACACB BCORL1 TNRC6B IRF3 NFIB PRRC2C WDR20 KMT2A MLLT1 MGA SAP130 HOMEZ PML POM121C NCOR2 KMT2D KHDRBS1 ZFHX4 ELF1 ELF4 ELK4 CTTN SRRM2 SPEN	1.88e-06	1429	223	26	35140242
Pubmed	Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER.	DNM1 DNM3 CTTN	2.58e-06	5	223	3	9722593
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD PPRC1 TNRC6B SMC5 TENM2 ZBED4 PRRC2C MCM3AP TET3 RALGAPB DNM3 SRRM2 SPEN	2.64e-06	407	223	13	12693553
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	XIRP1 PDZD7 CASZ1 TET3 CRAMP1 RGS3 SHANK3 XIRP2 LTK SRRM2	2.96e-06	233	223	10	37704626
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	IRF2BP2 MAP1A TNRC6B MCM3AP MGA NOTCH1 NCOR2 KMT2D SPEN	3.23e-06	184	223	9	32908313
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SRRM1 GBF1 ACACB PRR14 PLEKHA7 AATK CDK13 ERRFI1 PCNX1 LTK SRRM2 SPEN UNC80	3.72e-06	420	223	13	28065597
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ATXN2L DAG1 RB1CC1 EPS15L1 CASKIN2 FMN1 PLCB3 PLEKHA7 WIPF2 NOTCH1 PLEKHA6 MICALL1 TNKS1BP1 CTTN EIF2A	4.32e-06	565	223	15	25468996
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD NES ZNF219 APC2 TNRC6B TENM2 EPS15L1 PRRC2C SYN1 DNM1 MGA SHANK1 PRR36 KIF21A NOL9 GRM5 SHANK3 NCOR2 DNM3 CTTN	4.61e-06	963	223	20	28671696
Pubmed	MLL associates specifically with a subset of transcriptionally active target genes.	KMT2A MLLT1 KMT2D	5.13e-06	6	223	3	16199523
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CYLD GBF1 ACACB TNRC6B ZFP36L2 AMOTL1 PLEKHA7 NOTCH1 CRTC3 RALGAPB RAB11FIP1 EIF4EBP1 IRS2	7.09e-06	446	223	13	24255178
Pubmed	Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.	ERRFI1 TNK2 LTK	8.93e-06	7	223	3	19815557
Pubmed	IL-4/IL-13 signaling beyond JAK/STAT.	DOK2 IRS2 IL4R	8.93e-06	7	223	3	10856136
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CYLD MAP1A TNRC6B MAST4 FBXO42 FAM193B RC3H2 AKAP11 TNKS1BP1	9.06e-06	209	223	9	36779422
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	DAG1 KCNB2 DNM1 RALGAPB BCAR1 SHANK3 CELSR3 DNM3 RIMS2 SPEN SOS1	1.03e-05	329	223	11	17474147
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TNRC6B DENND2B CASZ1 TSC22D1 EPS15L1 NFIB RIN2 FBXO42 LUZP2 PRKAG2 SAP130 TET3 CRAMP1 ESPN STXBP5L UVSSA RALGAPB BCAR1 HIVEP3 ARHGAP6 NCOR2 CDK13 ANKRD11 TNK2 ELK4	1.20e-05	1489	223	25	28611215
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	CYLD IRF3 SEC24D EPS15L1 ZFP36L2 MCM3AP WDR20 GAREM1 CRTC3 DDX17 WEE1 PLEKHA6 NOL9 RAB11FIP1 ZFP36 TBC1D17 ARAP3 ERRFI1 TNKS1BP1 IRS2	1.37e-05	1038	223	20	26673895
Pubmed	L-serine deficiency caused by genetic Phgdh deletion leads to robust induction of 4E-BP1 and subsequent repression of translation initiation in the developing central nervous system.	NOTCH1 EIF4EBP1 EIF2A	1.42e-05	8	223	3	23350942
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ATXN2L ZFP36L2 MCM3AP KMT2A SAP130 POM121C KMT2D KHDRBS1 TNKS1BP1 SRRM2 SPEN	1.43e-05	341	223	11	32971831
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD ATXN2L ACACB MAP1A ADGRB1 DAG1 TNRC6B KCNB2 TENM2 EPS15L1 PRRC2C SHANK1 DDX17 STXBP5L USP24 TACC2 GRM5 SHANK3 PITPNM1 PITPNM3 CTTN	1.60e-05	1139	223	21	36417873
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	IRF2BP2 NFIB SAP130 NCOR2 KMT2D SPEN	1.62e-05	83	223	6	28794006
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ACACB BCORL1 TNRC6B RB1CC1 MGA HOMEZ USP24 NCOR2 KMT2D ZFHX4 TNKS1BP1 IRS2	1.86e-05	418	223	12	34709266
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF219 IRF3 TSC22D1 PRR14 ZBED4 ZFP36L2 NFIB PLAGL2 MGA PML CUX2 NR1H3 RFX2 ZFP36 THAP7 HIVEP3 ELF1	2.08e-05	808	223	17	20412781
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CASKIN2 PRRC2C KMT2A PLCB3 DNM1 RC3H2 RALGAPB AMBRA1 CC2D1B NOL9 RGS3 TBC1D17 ARHGEF40 ARAP3 CDK13	2.25e-05	650	223	15	38777146
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	ATXN2L SRRM1 TNRC6B PRRC2C MCM3AP SAP130 CRTC3 DDX17 AMBRA1 SCAMP3 POM121C NCOR2 CDK13 CTTN SRRM2	2.45e-05	655	223	15	35819319
Pubmed	Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.	TENM2 KMT2A TET3 SHANK1 HIVEP3 AKAP11	2.58e-05	90	223	6	15033168
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	SRRM1 RB1CC1 RIN2 KMT2A MLLT1 PRKAG2 DYRK2 WEE1 BCAR1 NCOR2 ARHGEF40 CDK13 ERRFI1 DNM3 TNK2 AKAP11 CTTN SOS1	2.67e-05	910	223	18	36736316
Pubmed	Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development.	NRXN3 STXBP5L KIF21A KHDRBS1	2.99e-05	28	223	4	38324473
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CYLD ATXN2L MAP1A BCORL1 PRRC2C FBXO42 MCM3AP PML WEE1 TACC2 BCAR1 NCOR2 TNKS1BP1 SPEN	3.02e-05	588	223	14	38580884
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	PRRC2C POM121C THAP7 SRRM2	3.45e-05	29	223	4	17577209
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L IRF2BP2 ACACB MAP1A TNRC6B EPS15L1 PRRC2C KMT2A PML USP36 FAM193B DDX17 TACC2 POM121C TNKS1BP1 IRS2 CTTN EIF2A	3.74e-05	934	223	18	33916271
Pubmed	The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.	KMT2A MLLT1	4.09e-05	2	223	2	36435883
Pubmed	Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice.	SHANK1 SHANK3	4.09e-05	2	223	2	33402706
Pubmed	Cloning of a novel human ELF-1-related ETS transcription factor, ELFR, its characterization and chromosomal assignment relative to ELF-1.	ELF1 ELF4	4.09e-05	2	223	2	9524226
Pubmed	Emergence of Xin demarcates a key innovation in heart evolution.	XIRP1 XIRP2	4.09e-05	2	223	2	18682726
Pubmed	Notch1 regulates hepatic thrombopoietin production.	NOTCH1 THPO	4.09e-05	2	223	2	38603632
Pubmed	Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.	KMT2A MLLT1	4.09e-05	2	223	2	8378076
Pubmed	Dynamin is primed at endocytic sites for ultrafast endocytosis.	DNM1 DNM3	4.09e-05	2	223	2	35809574
Pubmed	Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies.	NES ADGRB1	4.09e-05	2	223	2	25376607
Pubmed	The SRm160/300 splicing coactivator subunits.	SRRM1 SRRM2	4.09e-05	2	223	2	10668804
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2A KMT2D	4.09e-05	2	223	2	26711341
Pubmed	A dynamin 1-, dynamin 3- and clathrin-independent pathway of synaptic vesicle recycling mediated by bulk endocytosis.	DNM1 DNM3	4.09e-05	2	223	2	24963135
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2A KMT2D	4.09e-05	2	223	2	24423662
Pubmed	Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia.	PML NCOR2	4.09e-05	2	223	2	11585900
Pubmed	Crystal structure of the dynamin tetramer.	DNM1 DNM3	4.09e-05	2	223	2	26302298
Pubmed	Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism.	GRM5 SHANK3	4.09e-05	2	223	2	27161151
Pubmed	Rab11-dependent Recycling of the Human Ether-a-go-go-related Gene (hERG) Channel.	KCNH2 RAB11FIP1	4.09e-05	2	223	2	26152716
Pubmed	Aquaporin-4 Cell-Surface Expression and Turnover Are Regulated by Dystroglycan, Dynamin, and the Extracellular Matrix in Astrocytes.	DAG1 DNM1	4.09e-05	2	223	2	27788222
Pubmed	Classical dynamin DNM1 and DNM3 genes attain maximum expression in the normal human central nervous system.	DNM1 DNM3	4.09e-05	2	223	2	24673776
Pubmed	Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.	KMT2A MLLT1	4.09e-05	2	223	2	17252016
Pubmed	Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications.	KMT2A TET3	4.09e-05	2	223	2	30352306
Pubmed	Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation.	CHAF1B NCOR2	4.09e-05	2	223	2	32508530
Pubmed	Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.	KMT2A MLLT1	4.09e-05	2	223	2	21953510
Pubmed	Interleukin-4 activates two distinct pathways of phosphatidylinositol-3 kinase in the same cells.	IRS2 IL4R	4.09e-05	2	223	2	8954948
Pubmed	MAST4 regulates stem cell maintenance with DLX3 for epithelial development and amelogenesis.	MAST4 DLX3	4.09e-05	2	223	2	38945953
Pubmed	Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients.	DNM1 DNM3	4.09e-05	2	223	2	20700106
Pubmed	The Structural and Functional Integrity of Rod Photoreceptor Ribbon Synapses Depends on Redundant Actions of Dynamins 1 and 3.	DNM1 DNM3	4.09e-05	2	223	2	38641407
Pubmed	Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.	KMT2A MLLT1	4.09e-05	2	223	2	19029444
Pubmed	T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements.	KMT2A NOTCH1	4.09e-05	2	223	2	19631984
Pubmed	Reduced release probability prevents vesicle depletion and transmission failure at dynamin mutant synapses.	DNM1 DNM3	4.09e-05	2	223	2	22308498
Pubmed	The Xin repeat-containing protein, mXinβ, initiates the maturation of the intercalated discs during postnatal heart development.	XIRP1 XIRP2	4.09e-05	2	223	2	23261932
Pubmed	Shank3 regulates striatal synaptic abundance of Cyld, a deubiquitinase specific for Lys63-linked polyubiquitin chains.	CYLD SHANK3	4.09e-05	2	223	2	31215654
Pubmed	Structure, Expression, and Function of a Novel Intercalated Disc Protein, Xin.	XIRP1 XIRP2	4.09e-05	2	223	2	16708114
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	NPIPB12 DAG1 TSC22D1 PLCB3 PLEKHA7 WIPF2 NOTCH1 DYRK2 FAM193B COL6A3 CRTC3 USP24 CCDC80 CC2D1B TACC2 BCAR1 NCOR2 KHDRBS1 TNK2 ELF4 RIMS2	4.10e-05	1215	223	21	15146197
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	DENND2B WEE1 BCAR1 ERRFI1 IRS2 SRRM2	5.24e-05	102	223	6	15778465
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CHAF1B RB1CC1 PRRC2C KMT2A PML RC3H2 KMT2D CDK13 TNKS1BP1 H2BC20P EIF2A SPEN	5.67e-05	469	223	12	27634302
Pubmed	Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.	ERRFI1 TNK2 IRS2 SOS1	5.82e-05	33	223	4	18271526
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L TNRC6B EPS15L1 PRRC2C AMOTL1 KMT2A MGA SAP130 USP24 KMT2D TNKS1BP1 CTTN SPEN	6.14e-05	549	223	13	38280479
Pubmed	FCHo proteins are nucleators of clathrin-mediated endocytosis.	FCHO1 EPS15L1 DNM1	7.09e-05	13	223	3	20448150
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	IRF2BP2 CHAF1B BCORL1 KMT2A MGA SAP130 PML NOL9 ELF1 SPEN	7.43e-05	339	223	10	30415952
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CYLD ATXN2L GBF1 MAP1A TNRC6B SMC5 PRRC2C MGA USP36 RC3H2 MICALL1 TMEM131 CTTN EIF2A SPEN	7.60e-05	724	223	15	36232890
Pubmed	Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.	EPS15L1 AMOTL1 TRIM8 SYN1 WIPF2 SOS1	8.40e-05	111	223	6	22558309
Pubmed	Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses.	SHANK1 GRM5 SHANK3	8.99e-05	14	223	3	21795692
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	MAP1A KCNB2 DNM1 SHANK1 GRM5 SHANK3 PITPNM1 AKAP11 RIMS2	9.16e-05	281	223	9	28706196
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATXN2L IRF2BP2 BCORL1 PTPN22 PRRC2C KMT2A PLAGL2 SAP130 HOMEZ PML DDX17 NCOR2 KMT2D KHDRBS1 CDK13 ELF1 EIF2A SRRM2 SPEN	1.01e-04	1103	223	19	34189442
Pubmed	Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.	APC2 KMT2A KMT2D	1.12e-04	15	223	3	16510875
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	ACACB MAP1A EPS15L1 MGA RTL8C CRAMP1 CTTN EIF2A	1.13e-04	226	223	8	31452512
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	NES CARHSP1 RB1CC1 SMC5 EPS15L1 PRRC2C WIPF2 PML TNKS1BP1 SRRM2	1.22e-04	360	223	10	33111431
Interaction	SH3KBP1 interactions	IRF2BP2 SRRM1 DENND2A ZNF219 GGN DAG1 SEC24D CASKIN2 DNM1 WIPF2 DDX17 BCAR1 ZFP36 MICALL1 AATK ARAP3 KHDRBS1 SRRM2 SOS1	1.44e-09	315	216	19	int:SH3KBP1
Interaction	TOP3B interactions	GBF1 PPRC1 THAP8 TNRC6B STK11IP CASZ1 EPS15L1 ZBED4 ZFP36L2 KCNH2 MCM3AP IFRD2 MLLT1 CRAMP1 NOTCH1 GAREM1 FAM193B RC3H2 AMBRA1 POM121C TESK1 ZFP36 TBC1D17 MICALL1 HIVEP3 NCOR2 ARHGEF40 KMT2D AATK ARAP3 CELSR3 CDK13 ANKRD11 TNK2 PCNX1 TNKS1BP1 IRS2 LTK EIF2A SPEN ALKBH6 IL4R	4.18e-09	1470	216	42	int:TOP3B
Interaction	YWHAG interactions	KIAA0408 CYLD ATXN2L SRRM1 GBF1 RB1CC1 DENND2B MAST4 ZFP36L2 CASKIN2 PRRC2C WDR20 KMT2A PLEKHA7 GAREM1 HOMEZ RC3H2 CRTC3 DDX17 WEE1 RALGAPB USP24 PLEKHG2 BCAR1 RAB11FIP1 TESK1 SHANK3 ZFP36 MICALL1 ERRFI1 ANKRD11 GPSM3 TNK2 AKAP11 IRS2 SRRM2 SMTNL2 OTOG	4.77e-09	1248	216	38	int:YWHAG
Interaction	YWHAH interactions	CYLD ATXN2L SRRM1 NES GBF1 RB1CC1 DENND2B MAST4 ZFP36L2 CASKIN2 KCNH2 PRRC2C WDR20 KMT2A PLEKHA7 HOMEZ CRTC3 WEE1 RALGAPB PLEKHG2 BCAR1 RAB11FIP1 TESK1 ZFP36 MICALL1 ERRFI1 ANKRD11 GPSM3 AKAP11 TNKS1BP1 IRS2 RIMS2 SRRM2 SMTNL2 OTOG	7.34e-09	1102	216	35	int:YWHAH
Interaction	YWHAE interactions	CYLD ATXN2L CHAF1B GBF1 RB1CC1 SMC5 DENND2B MAST4 ZFP36L2 KCNH2 AMOTL1 WDR20 SYN1 KMT2A MGA PLEKHA7 SAP130 GAREM1 RC3H2 CRTC3 RALGAPB TACC2 BCAR1 RAB11FIP1 RGS3 SHANK3 MICALL1 NCOR2 CDK13 ERRFI1 GPSM3 AKAP11 IRS2 RIMS2 SRRM2 SMTNL2 OTOG	1.87e-08	1256	216	37	int:YWHAE
Interaction	YWHAB interactions	CYLD ATXN2L CHAF1B GBF1 RB1CC1 DENND2B MAST4 ZFP36L2 WDR20 KMT2A PLEKHA7 SAP130 HOMEZ RC3H2 CRTC3 WEE1 RALGAPB BCAR1 RAB11FIP1 TESK1 RGS3 SHANK3 ZFP36 MICALL1 ERRFI1 GPSM3 AKAP11 IRS2 SRRM2 SMTNL2 OTOG	1.38e-07	1014	216	31	int:YWHAB
Interaction	GRB2 interactions	KIAA0408 CYLD MAP1A GGN DAG1 PTPN22 EPS15L1 SYN1 DNM1 CLNK PLEKHA7 WIPF2 GAREM1 HOMEZ DDX17 ABI3BP C21orf58 BCAR1 SHANK3 KHDRBS1 ERRFI1 DNM3 TNK2 IRS2 LTK CTTN SOS1	1.62e-07	806	216	27	int:GRB2
Interaction	NCK1 interactions	DAG1 FCHO1 CASKIN2 DNM1 WIPF2 HOMEZ DOK2 BCAR1 SHANK3 AATK KHDRBS1 FAM217B TNK2 SOS1	4.12e-07	244	216	14	int:NCK1
Interaction	NCK2 interactions	KIAA0408 FAM47A GGN CASKIN2 DNM1 WIPF2 GAREM1 HOMEZ DOK2 BCAR1 KHDRBS1 FAM217B TNK2 SOS1	9.68e-07	262	216	14	int:NCK2
Interaction	SFN interactions	KIAA0408 CYLD ATXN2L GBF1 MAP1A DENND2B MAST4 ZFP36L2 NFIB PRRC2C KMT2A PLEKHA7 SAP130 CRTC3 WEE1 BCAR1 RAB11FIP1 ZFP36 ERRFI1 AKAP11 IRS2 SRRM2 SMTNL2	1.63e-06	692	216	23	int:SFN
Interaction	ASF1A interactions	IRF2BP2 CHAF1B BCORL1 CASZ1 MSL3 KMT2A MGA SAP130 PML NCOR2 KMT2D CTTN SPEN	3.08e-06	249	216	13	int:ASF1A
Interaction	YWHAZ interactions	CYLD ATXN2L CHAF1B GBF1 RB1CC1 SMC5 DENND2B MAST4 ZFP36L2 AMOTL1 WDR20 SYN1 KMT2A PLEKHA7 GAREM1 HOMEZ PML CRTC3 WEE1 RALGAPB TACC2 BCAR1 RAB11FIP1 RGS3 SHANK3 MICALL1 ERRFI1 GPSM3 TNK2 AKAP11 IRS2 SMTNL2 OTOG	4.60e-06	1319	216	33	int:YWHAZ
Interaction	NUP43 interactions	SRRM1 ACACB TNRC6B ZFP36L2 PRRC2C MCM3AP KMT2A MGA USP36 DDX17 NOL9 POM121C NCOR2 KMT2D ANKRD11 ELF1 ELF4 EIF2A SRRM2 SPEN	1.40e-05	625	216	20	int:NUP43
Interaction	TLE3 interactions	IRF2BP2 BCORL1 NFIB MCM3AP KMT2A SAP130 NOTCH1 CRTC3 DDX17 NCOR2 FOXB1 KMT2D TNKS1BP1 SRRM2 SPEN	1.42e-05	376	216	15	int:TLE3
Interaction	CD2AP interactions	GBF1 SMC5 SEC24D TSC22D1 PML BCAR1 MICALL1 ARAP3 KHDRBS1 CTTN SOS1	2.07e-05	214	216	11	int:CD2AP
Interaction	EN1 interactions	NFIB KMT2A MGA SAP130 NCOR2 KMT2D ZFHX4 SRRM2	2.46e-05	110	216	8	int:EN1
Interaction	PLCG1 interactions	SYN1 PLCB3 DNM1 GAREM1 PML DOK2 MICALL1 KHDRBS1 ERRFI1 IRS2 LTK SOS1	2.96e-05	264	216	12	int:PLCG1
Interaction	TBXT interactions	IRF2BP2 NFIB SAP130 HOMEZ NCOR2 KMT2D ZFHX4 SPEN	3.60e-05	116	216	8	int:TBXT
Interaction	SH3GL2 interactions	ZNF219 PRR14 SYN1 DNM1 TCEA2 SHANK3 DNM3	4.49e-05	88	216	7	int:SH3GL2
Interaction	CNOT6L interactions	CHAF1B TNRC6B ZSCAN1 RC3H2 ZFP36 TNKS1BP1 TMEM131	6.40e-05	93	216	7	int:CNOT6L
Interaction	CNOT3 interactions	ATXN2L SRRM1 MAP1A TNRC6B PRRC2C RC3H2 ZFP36 TNKS1BP1 TMEM131 CTTN	8.29e-05	207	216	10	int:CNOT3
Interaction	DENND2A interactions	DENND2A DENND2B TNK2	9.73e-05	9	216	3	int:DENND2A
Interaction	EPS15L1 interactions	CYLD GBF1 SMC5 FCHO1 EPS15L1 GAREM1 PML SOS1	1.23e-04	138	216	8	int:EPS15L1
Interaction	GOLGA2 interactions	NES GBF1 GGN SYNPO2L FAM161B CASZ1 FBXO42 MCM3AP SAP130 NOTCH1 TCEA2 FAM193B THAP7 BCL6B NCOR2 KMT2D AATK TXLNB ANKRD11 IL4R	1.29e-04	733	216	20	int:GOLGA2
Interaction	GSK3A interactions	CYLD SRRM1 ACACB MAP1A TNRC6B MAST4 FBXO42 FAM193B RC3H2 KIF21A BCAR1 KHDRBS1 AKAP11 TNKS1BP1 SRRM2	1.53e-04	464	216	15	int:GSK3A
Interaction	NFIX interactions	IRF2BP2 NFIB KMT2A MGA SAP130 NCOR2 KMT2D ZFHX4 ELF1 SPEN	1.77e-04	227	216	10	int:NFIX
Interaction	KLF3 interactions	IRF2BP2 BCORL1 NFIB KMT2A MGA SAP130 SCAMP3 NCOR2 KMT2D ELF1	1.83e-04	228	216	10	int:KLF3
Interaction	CRK interactions	GBF1 PTPN22 PRR14 SYN1 CLNK GAREM1 WEE1 DOK2 BCAR1 KHDRBS1 IRS2 SPEN SOS1	1.90e-04	370	216	13	int:CRK
Interaction	ITSN2 interactions	TNRC6B EPS15L1 SYN1 WIPF2 GAREM1 AATK KHDRBS1 SOS1	1.91e-04	147	216	8	int:ITSN2
Interaction	SGIP1 interactions	EPS15L1 RALGAPB SHANK3 NCOR2 TNK2	1.93e-04	50	216	5	int:SGIP1
GeneFamily	PDZ domain containing	SYNPO2L PDZD7 MAST4 SHANK1 HTRA2 RGS3 SHANK3 RIMS2	1.50e-05	152	131	8	1220
GeneFamily	Sterile alpha motif domain containing	CASKIN2 SHANK1 SHANK3 SCML4 ARAP3 L3MBTL1	4.30e-05	88	131	6	760
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DNM1 PLEKHA7 PLEKHG2 PLEKHA6 ARAP3 DNM3 IRS2 SOS1	1.29e-04	206	131	8	682
GeneFamily	Ankyrin repeat domain containing	BCORL1 CASKIN2 NOTCH1 SHANK1 ESPN SHANK3 ARAP3 ANKRD11	3.86e-04	242	131	8	403
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6B NCOR2 KMT2D	7.61e-04	25	131	3	775
GeneFamily	Phosphatidylinositol transfer proteins	PITPNM1 PITPNM3	7.67e-04	6	131	2	1151
GeneFamily	ETS transcription factor family	ELF1 ELF4 ELK4	1.07e-03	28	131	3	534
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	CC2D1B RAB11FIP1 RGS3	2.23e-03	36	131	3	823
GeneFamily	Zinc fingers CXXC-type	KMT2A TET3	3.28e-03	12	131	2	136
GeneFamily	THAP domain containing	THAP8 THAP7	3.28e-03	12	131	2	65
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	HOMEZ ZFHX4	5.14e-03	15	131	2	529
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CYLD APC2 ADGRB1 PDZD7 RB1CC1 TENM2 CASZ1 NRXN3 MAST4 DNM1 NPNT DYRK2 KIF21A PLEKHA6 VWCE GRM5 SEC31B SHANK3 HIVEP3 AATK CELSR3 ZFHX4 FAM217B DNM3 SORCS3 TNK2 RIMS2	8.39e-07	1106	222	27	M39071
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CYLD ATXN2L TNRC6B ZNF683 PTPN22 ARHGAP30 RB1CC1 SMC5 ZFP36L2 KMT2A NOTCH1 DYRK2 DDX17 RALGAPB USP24 DOK2 ZFP36 SCML4 HIVEP3 KMT2D KHDRBS1 CDK13 ANKRD11 GPSM3 TNK2 ELF1 PCNX1 AKAP11 ELK4 SPEN SOS1	3.61e-06	1492	222	31	M40023
Coexpression	GSE16266_CTRL_VS_LPS_STIM_MEF_UP	PLEKHA7 NOTCH1 CRTC3 RFX2 HIVEP3 NCOR2 ARHGEF40 ARAP3 ELF4 RELT	7.86e-06	198	222	10	M7219
Coexpression	VERHAAK_GLIOBLASTOMA_CLASSICAL	NES DENND2A LRFN3 DAG1 IRF3 RFX2 ARAP3 ZFHX4 IRS2	1.00e-05	161	222	9	M2121
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	TNRC6B MAST4 NFIB PRRC2C PLEKHA7 PLEKHA6 ARHGAP6 ERRFI1 ANKRD11 SRRM2	2.04e-05	221	222	10	M39222
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	NPIPB3 RB1CC1 SMC5 SEC24D TSC22D1 PLAGL2 WIPF2 NOTCH1 GAREM1 USP36 RALGAPB RAB11FIP1 ZFP36 TBC1D17 KHDRBS1 ELF1 PCNX1 IRS2 ELK4 SOS1	2.53e-05	822	222	20	M6782
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	CASZ1 PRR14 ZFP36L2 MCM3AP TRIM8 PLAGL2 NOTCH1 USP36 TCEA2 C21orf58 RENBP RAB11FIP1 ZFP36 PITPNM1 ANKRD11 TNK2 ELF4 TMEM131 SRRM2 SPEN ALKBH6	3.16e-05	905	222	21	M40865
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ATXN2L PPRC1 NPIPB3 ARHGAP30 IFRD2 CC2D1B SEC31B MICALL1 NUTM2E KMT2D TNK2 SRRM2	3.44e-05	338	222	12	M17094
Coexpression	HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN	IRF2BP2 ACACB MAST4 PLCB3 CRTC3 HIVEP3 EIF4EBP1	4.32e-05	110	222	7	M41010
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	APC2 PDZD7 TENM2 CASZ1 NRXN3 KIF21A PLEKHA6 SEC31B HIVEP3 AATK CELSR3 ZFHX4 DNM3 RIMS2	4.70e-05	465	222	14	M39066
Coexpression	GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	TNRC6B ARHGAP30 ZFP36L2 RAB11FIP1 KMT2D ARAP3 GPSM3 IRS2 IL4R	5.13e-05	198	222	9	M7948
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	PPRC1 TSC22D1 WIPF2 DYRK2 CRTC3 UVSSA BCAR1 BCL6B SOS1	5.33e-05	199	222	9	M7448
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	ACACB TNRC6B TENM2 FMN1 PRRC2C RIN2 PRKAG2 DNM1 PLEKHA7 PLEKHA6 ANKRD11 RIMS2 SRRM2	6.18e-05	417	222	13	M39224
Coexpression	ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN	SRRM1 ARHGAP30 PRRC2C SAP130 KMT2D SPEN	8.64e-05	85	222	6	M41085
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEC24D NRXN3 MAST4 FMN1 CLNK PLEKHA7 GAREM1 NPNT KIF21A ERRFI1 IRS2	3.10e-09	188	223	11	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CYLD NPIPB4 NPIPB5 PRRC2C KMT2A DDX17 USP24 SEC31B CDK13 ANKRD11	6.27e-08	197	223	10	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	KIAA0408 DENND2A KCNB2 KCNH2 NFIB ALOX12 COL6A3 ABI3BP CCDC80 ZFHX4	7.23e-08	200	223	10	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAST4 CASKIN2 MGA ALOX12 RALGAPB CCDC80 BCAR1 ARAP3 CD300LG	3.14e-07	179	223	9	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	droplet-Liver-Hepatocytes-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA1 WDR20 ALOX12 CUX2 ABI3BP CCDC80 BCAR1 ARAP3 CD300LG	4.15e-07	185	223	9	efcfbf5a48b3ea9a425183e5c2eec6a9585415a0
ToppCell	droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA1 WDR20 ALOX12 CUX2 ABI3BP CCDC80 BCAR1 ARAP3 CD300LG	4.15e-07	185	223	9	642088ace9230d38b0579853c54ff4dd8b5d5df4
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEC24D NRXN3 MAST4 FMN1 CLNK PLEKHA7 NPNT KIF21A ERRFI1	4.34e-07	186	223	9	e83718fabb057100835d3357df407f283d23fe16
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	NPIPB4 TNRC6B RB1CC1 KMT2A USP24 ANKRD11 PCNX1 TMEM131 SPEN	4.75e-07	188	223	9	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NES CARHSP1 CASZ1 CASKIN2 RIN2 SHANK3 BCL6B ARAP3 LTK	5.42e-07	191	223	9	1de0bdfd13bd930691564c2673f2e66393bc0255
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NPIPB4 NPIPB3 NPIPB5 FMN1 PLEKHA7 AMBRA1 PLEKHA6 ANKRD11 PCNX1	5.91e-07	193	223	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	ACACB TENM2 CASZ1 MAST4 PRKAG2 KIF21A TACC2 RGS3 HACD1	6.18e-07	194	223	9	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TSC22D1 LUZP2 STXBP5L USP24 TACC2 GRM5 DNM3 TNK2 UNC80	7.64e-07	199	223	9	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TSC22D1 LUZP2 STXBP5L USP24 TACC2 GRM5 DNM3 TNK2 UNC80	7.64e-07	199	223	9	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	IRF2BP2 ZFP36L2 KMT2A NOTCH1 DYRK2 WEE1 ZFHX4 TMEM131 IRS2	7.64e-07	199	223	9	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TSC22D1 LUZP2 STXBP5L USP24 TACC2 GRM5 DNM3 TNK2 UNC80	7.64e-07	199	223	9	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	MS-Multiple_Sclerosis-Others-Platelet\|Multiple_Sclerosis / Disease, condition lineage and cell class	MAP1A TSC22D1 NFIB ALOX12 ARHGAP6 AATK XIRP2 DNM3 CTTN	7.96e-07	200	223	9	263d956136747c209951b4358f2e1672a21d8eef
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	NPIPB4 TNRC6B PTPN22 ZFP36L2 PRRC2C KMT2A KIF21A SCML4	9.71e-07	151	223	8	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NES CHAF1B LRFN3 ADAD2 NOTCH1 BCL6B AATK PITPNM3	1.73e-06	163	223	8	1feb4ef7b8abcfca9a72c8d13c40548de79e7db2
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ZNF683 FCHO1 MAST4 FMN1 TRIM8 ABI3BP USP24 PCNX1	2.93e-06	175	223	8	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASKIN2 NOTCH1 TCEA2 CCDC80 SHANK3 NCOR2 CD300LG CTTN	2.93e-06	175	223	8	98dc3b6f69a29d587f503898f09912700950e3d9
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEC24D NRXN3 MAST4 FMN1 CLNK PLEKHA7 KIF21A ERRFI1	3.47e-06	179	223	8	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB CASZ1 TSC22D1 FMN1 USP24 TACC2 NUTM2E ARHGAP6	3.76e-06	181	223	8	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEC24D NRXN3 FMN1 CLNK GAREM1 NPNT KIF21A ERRFI1	4.25e-06	184	223	8	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 ALOX12 ARHGAP6 AATK XIRP2 DNM3 CTTN	4.42e-06	185	223	8	9bff336510c80cd762b4e41b4570475033e709ca
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 ALOX12 ARHGAP6 AATK XIRP2 DNM3 CTTN	4.42e-06	185	223	8	452d49c7835a4d55e41caefa44dac5cab30e7ced
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 ALOX12 ARHGAP6 AATK XIRP2 DNM3 CTTN	4.42e-06	185	223	8	53f5136ee1bd101dd5ac8a2c9e63b0c3b987657e
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCORL1 LUZP2 DLX3 PLCB3 CUX2 KIF21A CELSR3 ALKBH6	4.42e-06	185	223	8	edb114487206e4e8df4c7878285df40f49b7fd64
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 ALOX12 ARHGAP6 AATK XIRP2 DNM3 CTTN	4.42e-06	185	223	8	67ac5c2bacdbdcb40ee65c44da55b3f597b410ee
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRXN3 FMN1 CLNK PLEKHA7 GAREM1 KIF21A RAB11FIP1 ERRFI1	4.60e-06	186	223	8	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	Substantia_nigra-Neuronal\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KCNB2 TENM2 NRXN3 SYN1 DNM1 SHANK1 CELSR3 UNC80	4.60e-06	186	223	8	3f889083fcffe516388e9b03a5e23af2010ced33
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 KCNH2 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	4.79e-06	187	223	8	46e15419e80bd7180f3171a99d845b01bb635e53
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 KCNH2 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	4.79e-06	187	223	8	0d17b07770e4c881a7ca53a5bd42471457d198fb
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	ACACB TENM2 CASZ1 KIF21A TACC2 TXLNB XIRP2 HACD1	4.79e-06	187	223	8	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 KCNH2 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	4.79e-06	187	223	8	69068480f6819a6c8560ecbb05deb156b4055e12
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A TSC22D1 KCNH2 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	4.79e-06	187	223	8	9c8b932a15b8b50982cba4cf8db750e257eb9503
ToppCell	remission-Platelet\|World / disease stage, cell group and cell class	MAP1A TSC22D1 ALOX12 CARD19 ARHGAP6 XIRP2 DNM3 CTTN	4.98e-06	188	223	8	fa69f20ef6b8ce620ba342f0984d40ddf259bc3f
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SYNPO2L NTSR2 KCNH2 PLEKHA7 C21orf58 TXLNB XIRP2	5.18e-06	189	223	8	b98f60875b1a12b2ec9dc91889298ae57f98602f
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NES DENND2B CASKIN2 RIN2 SHANK3 BCL6B ARAP3 LTK	5.18e-06	189	223	8	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SYNPO2L NTSR2 KCNH2 PLEKHA7 C21orf58 TXLNB XIRP2	5.18e-06	189	223	8	e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCell	facs-Heart-LA-24m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES TSC22D1 NOTCH1 BCAR1 RGS3 BCL6B ARAP3 CD300LG	5.38e-06	190	223	8	911b93c4c828ef2d867b91a5eced2dc12a1baf27
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NES DENND2B CASKIN2 RIN2 LUZP2 SHANK3 ARAP3 LTK	5.38e-06	190	223	8	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	CASZ1 TSC22D1 NRXN3 MAST4 RIN2 ARHGAP6 CD300LG IL4R	5.38e-06	190	223	8	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TENM2 FCHO1 NRXN3 SYN1 KMT2A DNM1 CELSR3 UNC80	5.38e-06	190	223	8	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	TENM2 CASZ1 MAST4 PRKAG2 KIF21A TACC2 RGS3 HACD1	5.59e-06	191	223	8	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LVRN NFIB PRRC2C ABI3BP ZFHX4 ERRFI1 IRS2 SRRM2	5.59e-06	191	223	8	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZFP36L2 WEE1 UVSSA RENBP SPATA32 PITPNM1 RIMS2	5.68e-06	136	223	7	186be8e1595608004b8216892cb9c7a7f31fbb4d
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	NES DENND2B CASKIN2 RIN2 SHANK3 BCL6B ARAP3 LTK	5.81e-06	192	223	8	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFIB NPNT COL6A3 ABI3BP CCDC80 PLEKHA6 HIVEP3 EIF4EBP1	6.04e-06	193	223	8	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFIB NPNT COL6A3 ABI3BP CCDC80 PLEKHA6 HIVEP3 EIF4EBP1	6.04e-06	193	223	8	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NPIPB4 TNRC6B NPIPB3 PTPN22 NPIPB5 ZFP36L2 PLEKHA6 SCML4	6.04e-06	193	223	8	9c9434a3297b85774b4f0ecab6294f44d738e29f
ToppCell	PND01\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RB1CC1 CLCA1 RIN2 NPNT ZFP36 ERRFI1 ANKRD11 IRS2	6.04e-06	193	223	8	c291345c11cfcbceacbdc001a5851f67478a2779
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF683 PTPN22 ZFP36L2 CLNK SCML4 CELSR3 RIMS2	6.25e-06	138	223	7	769be787e24532d5e023f99f82c7272bddac40c3
ToppCell	COPD-Endothelial-VE_Capillary_B\|COPD / Disease state, Lineage and Cell class	NES NRXN3 CASKIN2 NFIB RIN2 SHANK3 ARAP3 CD300LG	6.27e-06	194	223	8	18b7f901c12ca4f21f9a1eafd092aefe4d668b6d
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 PRRC2C KMT2A MGA KIF21A ANKRD11 SRRM2 UNC80	6.51e-06	195	223	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 PRRC2C KMT2A MGA KIF21A ANKRD11 SRRM2 UNC80	6.51e-06	195	223	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNB2 TENM2 NRXN3 DNM1 STXBP5L GRM5 RIMS2 UNC80	6.76e-06	196	223	8	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	facs-GAT-Fat-3m-Endothelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES CLCA1 CASKIN2 BCAR1 SHANK3 BCL6B ARAP3 CD300LG	6.76e-06	196	223	8	b6cc1f466d45479764080d34b1daeb8243a5a9f3
ToppCell	facs-GAT-Fat-3m-Endothelial-endothelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES CLCA1 CASKIN2 BCAR1 SHANK3 BCL6B ARAP3 CD300LG	6.76e-06	196	223	8	ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8
ToppCell	facs-GAT-Fat-3m-Endothelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES CLCA1 CASKIN2 BCAR1 SHANK3 BCL6B ARAP3 CD300LG	6.76e-06	196	223	8	039044ab28c53391c34d8226fb8cf78549e63ef4
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PTPN22 FCHO1 CLNK CUX2 DOK2 ZFP36 RELT CCDC24	7.01e-06	197	223	8	8fa38fb95e285f9cc756ec4f32009be4ede09d3c
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIAA0408 TSC22D1 NFIB RIN2 NPNT COL6A3 ABI3BP ZFHX4	7.01e-06	197	223	8	3fe665c0277d091290b63f0dd24c0c6536a45309
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RNF217 TENM2 TSC22D1 COL6A3 CCDC80 RGS3 ZFHX4 ERRFI1	7.28e-06	198	223	8	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RNF217 TENM2 TSC22D1 COL6A3 CCDC80 RGS3 ZFHX4 ERRFI1	7.28e-06	198	223	8	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RNF217 TENM2 TSC22D1 COL6A3 CCDC80 RGS3 ZFHX4 ERRFI1	7.28e-06	198	223	8	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MAP1A NFIB DNM1 COL6A3 ABI3BP CCDC80 ZFHX4 CTTN	7.28e-06	198	223	8	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM2 TSC22D1 NRXN3 DNM1 STXBP5L GRM5 RIMS2 UNC80	7.28e-06	198	223	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM2 TSC22D1 NRXN3 DNM1 STXBP5L GRM5 RIMS2 UNC80	7.28e-06	198	223	8	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NES DLX3 NPNT COL6A3 CCDC80 RGS3 ZFHX4 ERRFI1	7.28e-06	198	223	8	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NES DLX3 COL6A3 ABI3BP CCDC80 RGS3 ZFHX4 ERRFI1	7.28e-06	198	223	8	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNB2 TSC22D1 NRXN3 DNM1 STXBP5L GRM5 RIMS2 UNC80	7.28e-06	198	223	8	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	KIAA0408 DENND2A KCNH2 NFIB LUZP2 COL6A3 ABI3BP ZFHX4	7.55e-06	199	223	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NPIPB4 NPIPB5 PRRC2C DDX17 USP24 SCML4 CDK13 ANKRD11	7.55e-06	199	223	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MAP1A DENND2B NFIB COL6A3 ABI3BP CCDC80 ZFHX4 CTTN	7.55e-06	199	223	8	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NES CASKIN2 RIN2 SHANK3 BCL6B ARHGAP6 ARAP3 LTK	7.55e-06	199	223	8	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NES DLX3 NPNT COL6A3 CCDC80 RGS3 ZFHX4 ERRFI1	7.83e-06	200	223	8	16a7c398626b6e82b394eb3ef013bda3a788659d
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	KCNB2 TENM2 NRXN3 DNM1 STXBP5L GRM5 RIMS2 UNC80	7.83e-06	200	223	8	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	NPIPB4 PTPN22 DDX17 SCML4 KMT2D AATK PCNX1	9.46e-06	147	223	7	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN22 ARHGAP30 ZFP36L2 CLNK DOK2 SCML4 GPSM3	1.34e-05	155	223	7	4ae91bc7dbb9f713a1f110c17834b1d89f1b28db
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN22 ARHGAP30 ZFP36L2 CLNK DOK2 SCML4 GPSM3	1.34e-05	155	223	7	1fb49b48e34e740118908951e079ea2a9994ae4f
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN22 ARHGAP30 ZFP36L2 CLNK DOK2 SCML4 GPSM3	1.34e-05	155	223	7	fdcc8a475156329b3594d5ed22ba03538305327c
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	TENM2 NRXN3 LUZP2 CUX2 STXBP5L GRM5 XIRP2	1.58e-05	159	223	7	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZNF683 ZBED4 FMN1 TRIM8 ABI3BP USP24 PCNX1	2.08e-05	166	223	7	c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCell	NS-critical-d_0-4-Epithelial-unknown_epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LRFN3 NPIPB3 ODAPH ESPN PLEKHA6 SCML4 ARHGAP6	2.08e-05	166	223	7	dd02bbe4af609c6348dc92417254f4740f2900a8
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	GBF1 DAG1 ZBED4 RGS3 L3MBTL1 MYO15A HACD1	2.25e-05	168	223	7	ca94b29c1030484143a77f2df06dad74d2c6136e
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic-platelet\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	2.61e-05	172	223	7	d588ca825ab301910c1378e009b766c809b0bd5e
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF683 ZBED4 FMN1 TRIM8 ABI3BP USP24 PCNX1	2.61e-05	172	223	7	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	2.61e-05	172	223	7	1a9b99c7fc297d9e4b6098bf0c4fb98927a05f6d
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACACB CRAMP1 PML SHANK3 SCML4 BCL6B ARAP3	2.71e-05	173	223	7	66488d01e03264fb193285470901c9c4182fbae8
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF219 APC2 ADGRB1 KIF21A NUTM2E MYO15A UNC80	2.81e-05	174	223	7	271c51d220842402975d97c86c9acfdbdf62a32c
ToppCell	356C-Lymphocytic-ILC\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZNF683 PTPN22 ZFP36L2 CLNK CARD19 ZFP36 SCML4	2.92e-05	175	223	7	7fa8330ce813c48bd332be618909e5ec8d0f5d7e
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	3.14e-05	177	223	7	e63d01c7fce4fa1256212fa7e95f74281edb3a01
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	3.14e-05	177	223	7	0830944c43de300815831a9e2b2fce40965e7d12
ToppCell	droplet-Limb_Muscle-nan-21m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GARIN5A LUZP2 NPNT DYRK2 ESPN AATK TXLNB	3.14e-05	177	223	7	291231b1520c135e92739e201495fe1935efa927
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	3.25e-05	178	223	7	f5d83ad082e31d5601890d245b9fb4f9ef6a062b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRRM1 NES PRRC2C ANKRD11 CD300LG ELK4 SRRM2	3.25e-05	178	223	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	3.25e-05	178	223	7	a2a8fc14f492a4695e6991a357b6626145f1bf7f
ToppCell	356C-Lymphocytic-ILC-ILC-1\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZNF683 PTPN22 ZFP36L2 CLNK CARD19 ZFP36 SCML4	3.25e-05	178	223	7	40df4bb0978e5e5568c52ad4a5881ea0cdc6941d
ToppCell	PBMC-Convalescent-Hematopoietic\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	3.37e-05	179	223	7	35271a4396a533f6d960ce55d171a32d9d2fd1a4
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	3.37e-05	179	223	7	906a5ebbbac660b6fd498ced09d0ada40a3e64af
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP1A TSC22D1 ALOX12 ARHGAP6 XIRP2 DNM3 CTTN	3.37e-05	179	223	7	510927794bbd21814eba75286e0801eb1fd2e8a6
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	BCORL1 DENND2B SEC24D MAST4 MCM3AP RHBDD3 DDX17 NR1H3 ARHGAP6 PCNX1 ELF4 IL4R	4.48e-07	197	217	12	4532_DN
Drug	Atracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A	TNRC6B MAST4 ZBED4 KCNH2 NFIB DNM1 TESK1 PITPNM1 CELSR3 CDK13 PCNX1 IRS2	4.99e-07	199	217	12	7477_UP
Drug	Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	LRFN3 SMC5 FCHO1 MAST4 ZBED4 CASKIN2 RTL10 MICALL1 CELSR3 TNK2 IRS2 ELK4	5.26e-07	200	217	12	3477_DN
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A	CASZ1 ZFP36L2 RHBDD3 GAREM1 PML DYRK2 RC3H2 USP24 ZFP36 PITPNM1 ARAP3 SRRM2	5.26e-07	200	217	12	7308_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CYLD FCHO1 MAST4 ZFP36L2 CASKIN2 KCNH2 PLAGL2 DNM1 CDK13 IRS2 SRRM2	2.74e-06	194	217	11	1707_DN
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CYLD TNRC6B ZFP36L2 KCNH2 PLAGL2 PLCB3 FAM193B DDX17 RGS3 TNK2 IL4R	2.88e-06	195	217	11	6821_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	ATXN2L SEC24D CLCA1 ZBED4 CASKIN2 RTL10 HIVEP3 NCOR2 CELSR3 CDK13 ELK4	3.03e-06	196	217	11	3716_DN
Drug	Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A	SEC24D NRXN3 MAST4 ZFP36L2 FBXO42 PML WEE1 USP24 AMBRA1 MICALL1 AATK	3.03e-06	196	217	11	4548_DN
Drug	Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF219 BCORL1 PRRC2C MSL3 PLAGL2 RHBDD3 FAM149B1 NR1H3 TACC2 TESK1 ELK4	3.03e-06	196	217	11	5249_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A	PTPN22 DENND2B CLCA1 ZFP36L2 NFIB RHBDD3 SLC22A18AS ZFHX4 CDK13 PCNX1 RIMS2	3.18e-06	197	217	11	4976_UP
Drug	U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A	CYLD DAG1 CASKIN2 WIPF2 TESK1 RGS3 HIVEP3 ARHGAP6 DNM3 PCNX1 ELK4	3.18e-06	197	217	11	4553_DN
Drug	1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one	NES DENND2B NRXN3 ZFP36L2 CASKIN2 AMOTL1 SYN1 PLCB3 PLEKHA7 NOTCH1 PML SHANK1 PLEKHG2 EIF4EBP1 DNM3	3.23e-06	373	217	15	ctd:C540355
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	ZNF219 GBF1 LRFN3 PRR14 CASKIN2 FAM149B1 DNM1 TBC1D17 PITPNM1 SLC22A18AS NALF2	3.34e-06	198	217	11	6016_DN
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ATXN2L MAP1A MAST4 CASKIN2 NFIB PRR36 L3MBTL1 PCNX1 IRS2 RIMS2 IL4R	3.51e-06	199	217	11	5540_UP
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A	FCHO1 MCM3AP KMT2A RHBDD3 FAM193B RC3H2 DDX17 HIVEP3 ELF4 SPEN IL4R	3.51e-06	199	217	11	1568_DN
Drug	Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; PC3; HT_HG-U133A	MAP1A LRFN3 TNRC6B CASKIN2 RHBDD3 PML PLEKHA6 PCNX1 IRS2 ELK4 CTTN	3.51e-06	199	217	11	6312_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	ATXN2L GBF1 ACACB DENND2B ZFP36L2 NOTCH1 PRR36 AMBRA1 CELSR3 SRRM2 NALF2	3.68e-06	200	217	11	3322_UP
Drug	Imipenem [74431-23-5]; Up 200; 13.4uM; HL60; HG-U133A	CYLD CHAF1B ZNF219 PRR14 FBXO42 HTRA2 AMBRA1 SEC31B ARHGEF40 L3MBTL1 IL4R	3.68e-06	200	217	11	1724_UP
Drug	Methamphetamine	ATXN2L SRRM1 GBF1 ACACB MAP1A CARHSP1 GARIN5A STK11IP PRRC2C DNM1 ZNF541 FAM193B DDX17 CC2D1B TACC2 RENBP PLEKHG2 PLEKHA6 GRM5 ZFP36 MICALL1 NCOR2 THPO ARAP3 L3MBTL1 EIF4EBP1 ERRFI1 ANKRD11 SORCS3 LTK RIMS2 SRRM2	3.88e-06	1401	217	32	ctd:D008694
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	SMC5 PRRC2C KMT2A DYRK2 RC3H2 DDX17 ANKRD11 ELF1 SRRM2 SPEN	8.50e-06	178	217	10	3998_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	CHAF1B ACACB DAG1 NFIB MCM3AP GAREM1 PML HIVEP3 ARHGEF40 SRRM2	1.57e-05	191	217	10	4454_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	TNRC6B CLCA1 MAST4 ZFP36L2 CASKIN2 PML USP36 RIMS2 SRRM2 KLHDC4	1.72e-05	193	217	10	1647_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ATXN2L CASZ1 SEC24D EPS15L1 ZFP36L2 PML DDX17 PITPNM1 ELF4 SPEN	1.72e-05	193	217	10	2209_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A	ATXN2L SMC5 NFIB DYRK2 TCEA2 AMBRA1 RGS3 ZFP36 IRS2 MYO15A	1.72e-05	193	217	10	455_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ACACB PTPN22 ZFP36L2 MSL3 PML HIVEP3 NCOR2 PCNX1 RIMS2 NALF2	1.80e-05	194	217	10	4763_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A	DAG1 TNRC6B PRR14 MCM3AP PML AMBRA1 TBC1D17 CDK13 ELF4 SOS1	1.80e-05	194	217	10	4572_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A	ACACB DENND2B NRXN3 ZFP36L2 WIPF2 PML AMBRA1 PITPNM1 L3MBTL1 DNM3	1.80e-05	194	217	10	4559_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	ACACB PPRC1 CASKIN2 KMT2A NOTCH1 PML DYRK2 RC3H2 NR1H3 MICALL1	1.80e-05	194	217	10	4524_DN
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A	BCORL1 EPS15L1 ZFP36L2 FBXO42 MCM3AP PRKAG2 SEC31B PITPNM1 CTTN SOS1	1.80e-05	194	217	10	3035_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	BCORL1 TNRC6B SEC24D NFIB WEE1 RGS3 CELSR3 ELF4 SRRM2 NALF2	1.80e-05	194	217	10	990_DN
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	MAST4 NFIB KMT2A PML HTRA2 RTL10 PLEKHA6 ELF4 IRS2 ELK4	1.88e-05	195	217	10	7434_UP
Drug	Prednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A	GBF1 SEC24D FBXO42 MSL3 PLCB3 PML AMBRA1 HIVEP3 CDK13 IL4R	1.97e-05	196	217	10	2393_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CASZ1 SEC24D MSL3 WIPF2 GAREM1 PML DDX17 RTL10 PCNX1 ELK4	1.97e-05	196	217	10	7356_DN
Drug	Vinpocetine [42971-09-5]; Up 200; 11.4uM; HL60; HG-U133A	ATXN2L ADM2 DAG1 SMC5 FAM149B1 RTL10 RAB11FIP1 MICALL1 ARHGEF40 KLHDC4	1.97e-05	196	217	10	1557_UP
Drug	Lysergol [602-85-7]; Up 200; 15.8uM; MCF7; HT_HG-U133A	KCNH2 RIN2 PLCB3 RTL10 DOK2 AATK KHDRBS1 ZFHX4 IRS2 RIMS2	1.97e-05	196	217	10	3261_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A	ATXN2L ACACB ADM2 NRXN3 KCNH2 MSL3 RHBDD3 ARHGEF40 LTK RIMS2	2.05e-05	197	217	10	4433_UP
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A	ACACB PLCB3 PML DYRK2 USP24 PITPNM1 TNK2 SRRM2 SPEN IL4R	2.05e-05	197	217	10	4556_DN
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	APC2 SEC24D ZFP36L2 PML ABI3BP POM121L2 PITPNM1 SLC22A18AS IRS2 RIMS2	2.05e-05	197	217	10	2637_UP
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ATXN2L NFIB MSL3 PLCB3 PML USP36 DDX17 RGS3 DNM3 PCNX1	2.05e-05	197	217	10	4730_DN
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ZFP36L2 CASKIN2 RIN2 PML PITPNM1 HIVEP3 CDK13 PCNX1 ELF4 ELK4	2.05e-05	197	217	10	3300_DN
Drug	Lansoprazole [103577-45-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A	BCORL1 DAG1 PTPN22 SEC24D CLCA1 MAST4 ZFP36L2 PML ABI3BP PITPNM1	2.05e-05	197	217	10	3529_DN
Drug	Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; MCF7; HT_HG-U133A	ZFP36L2 KCNH2 FBXO42 MSL3 PML WEE1 RTL10 TESK1 ELF4 RIMS2	2.15e-05	198	217	10	7359_DN
Drug	5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA	ZFP36L2 NFIB PRRC2C PRR36 NR1H3 PLEKHA6 MICALL1 ELF1 IRS2 SPEN	2.15e-05	198	217	10	889_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	SEC24D ZBED4 NFIB TESK1 RGS3 DNM3 PCNX1 ELF4 IRS2 ELK4	2.15e-05	198	217	10	5259_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A	ATXN2L ZFP36L2 MSL3 PLCB3 RTL10 AMBRA1 POM121L2 TESK1 SLC22A18AS TNK2	2.15e-05	198	217	10	3112_DN
Drug	Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	BCORL1 PTPN22 CASKIN2 KMT2A FAM149B1 MICALL1 PITPNM1 ZFHX4 PCNX1 ELK4	2.15e-05	198	217	10	4142_UP
Drug	Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A	CYLD SEC24D MAST4 PRKAG2 PML DDX17 WEE1 TACC2 IRS2 IL4R	2.15e-05	198	217	10	7018_UP
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Up 200; 15.6uM; MCF7; HT_HG-U133A	SEC24D NFIB FAM149B1 RTL10 TBC1D17 NCOR2 CELSR3 ZFHX4 PCNX1 IRS2	2.15e-05	198	217	10	7481_UP
Drug	Ribavirin [36791-04-5]; Down 200; 16.4uM; HL60; HT_HG-U133A	CYLD GBF1 PLCB3 NOTCH1 PML ARHGEF40 L3MBTL1 ZFHX4 DNM3 IL4R	2.15e-05	198	217	10	3142_DN
Drug	Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; HL60; HG-U133A	CYLD BCORL1 KCNH2 FBXO42 RHBDD3 DNM1 HIVEP3 NCOR2 ARHGEF40 AATK	2.15e-05	198	217	10	1985_UP
Drug	Tomatidine [77-59-8]; Down 200; 9.6uM; PC3; HT_HG-U133A	TNRC6B PRR14 NFIB FBXO42 DYRK2 FAM193B WEE1 NR1H3 PLEKHA6 ELF1	2.24e-05	199	217	10	5808_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; PC3; HT_HG-U133A	ACACB NFIB MSL3 PML PLEKHA6 PITPNM1 ARHGAP6 L3MBTL1 IRS2 ELK4	2.24e-05	199	217	10	5730_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A	ZNF219 DENND2B MAST4 NFIB RIN2 PML ZFP36 TNK2 ELK4 IL4R	2.24e-05	199	217	10	2855_DN
Drug	Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A	RB1CC1 ZFP36L2 KMT2A FAM149B1 PML PRR36 PLEKHA6 TBC1D17 RIMS2 NALF2	2.24e-05	199	217	10	4140_UP
Drug	1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A	NES CHAF1B KMT2A RTL10 AMBRA1 ZFP36 SLC22A18AS PCNX1 ELF4 MYO15A	2.24e-05	199	217	10	1_UP
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	MAST4 CASKIN2 NFIB FAM149B1 DNM1 TBC1D17 ELF1 PCNX1 IRS2 IL4R	2.24e-05	199	217	10	6075_DN
Drug	Dimaprit dihydrochloride [23256-33-9]; Down 200; 17uM; MCF7; HT_HG-U133A	ZNF219 DAG1 KCNH2 RIN2 PLCB3 PRR36 WEE1 RTL10 NR1H3 HIVEP3	2.34e-05	200	217	10	6520_DN
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	ZNF219 SEC24D ZFP36L2 PLEKHA6 HIVEP3 AATK CELSR3 DNM3 SRRM2 IL4R	2.34e-05	200	217	10	6676_DN
Drug	LY294002; Up 200; 10uM; HL60; HG-U133A	ZNF219 DAG1 FBXO42 KMT2A PML STXBP5L TESK1 TBC1D17 SLC22A18AS ELF4	2.34e-05	200	217	10	361_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	ZFP36L2 NFIB TRIM8 USP24 TACC2 MICALL1 ELF4 ELK4 SRRM2	5.51e-05	178	217	9	992_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	ATXN2L RB1CC1 KCNH2 MSL3 KMT2A FAM149B1 GAREM1 RGS3 IRS2	7.73e-05	186	217	9	4460_UP
Drug	2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A	PPRC1 KCNB2 ZFP36L2 TRIM8 RHBDD3 PML DDX17 ARHGEF40 SRRM2	8.74e-05	189	217	9	410_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	MAST4 ZFP36L2 CASKIN2 KMT2A WIPF2 PML DDX17 L3MBTL1 ELF1	9.47e-05	191	217	9	6644_DN
Drug	Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A	CYLD ZFP36L2 KCNH2 PML DOK2 THPO L3MBTL1 TNK2 SOS1	9.47e-05	191	217	9	6461_UP
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A	CYLD ACACB NRXN3 CASKIN2 PLAGL2 RHBDD3 RGS3 ZFP36 SRRM2	1.03e-04	193	217	9	7153_DN
Drug	Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A	LRFN3 ZBED4 KCNH2 KMT2A DDX17 ABI3BP WEE1 CDK13 PCNX1	1.07e-04	194	217	9	3522_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	CYLD NFIB DDX17 ABI3BP NR1H3 TESK1 PCNX1 ELK4 SPEN	1.07e-04	194	217	9	4309_DN
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	CYLD ATXN2L MAP1A DENND2B CASKIN2 MCM3AP MICALL1 L3MBTL1 TNK2	1.07e-04	194	217	9	263_UP
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	BCORL1 PDZD7 RHBDD3 PML DDX17 RALGAPB TNK2 PCNX1 SOS1	1.07e-04	194	217	9	2504_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	CYLD DENND2A TNRC6B SEC24D NRXN3 MAST4 ZFP36L2 PML IRS2	1.11e-04	195	217	9	4533_DN
Drug	S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; HL60; HT_HG-U133A	ATXN2L ACACB MAP1A MCM3AP PML PLEKHA6 RFX2 ZFHX4 MYO15A	1.11e-04	195	217	9	3082_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CYLD PTPN22 DENND2B KMT2A PLCB3 DNM1 PRR36 HIVEP3 CDK13	1.11e-04	195	217	9	3941_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A	ZNF219 ACACB CASZ1 GAREM1 PLEKHA6 AATK L3MBTL1 CELSR3 TNK2	1.11e-04	195	217	9	3124_UP
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	CASKIN2 KCNH2 NFIB MCM3AP PML PLEKHA6 RGS3 CDK13 ELK4	1.11e-04	195	217	9	5329_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ZFP36L2 KCNH2 MSL3 PML USP36 DDX17 ABI3BP PCNX1 RIMS2	1.11e-04	195	217	9	2278_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A	ZNF219 FCHO1 MAST4 ZFP36L2 PLCB3 PRKAG2 ABI3BP PRR36 IRS2	1.11e-04	195	217	9	5283_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	CYLD ADM2 ZFP36L2 PML COL6A3 KHDRBS1 CDK13 PCNX1 IRS2	1.11e-04	195	217	9	2875_UP
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	ATXN2L PRRC2C KMT2A PML DDX17 AMBRA1 ANKRD11 ELF1 SRRM2	1.11e-04	195	217	9	6159_DN
Drug	monastrol; Down 200; 100uM; MCF7; HG-U133A	CHAF1B PPRC1 PDZD7 KCNB2 CASKIN2 NFIB PRRC2C DYRK2 ELF4	1.15e-04	196	217	9	610_DN
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	FCHO1 MAST4 DNM1 DDX17 RAB11FIP1 PCNX1 ELF4 IRS2 NALF2	1.15e-04	196	217	9	2874_DN
Drug	Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PTPN22 ZBED4 RIN2 FBXO42 MSL3 FAM149B1 CELSR3 CDK13 ELK4	1.15e-04	196	217	9	5411_DN
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	NES ACACB DENND2B KCNH2 MCM3AP PML AMBRA1 SLC22A18AS ELK4	1.15e-04	196	217	9	3187_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	ACACB BCORL1 DENND2B CLCA1 KMT2A RHBDD3 PRR36 KHDRBS1 ELK4	1.15e-04	196	217	9	2086_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	DENND2A GBF1 LRFN3 ZBED4 ZFP36L2 PLCB3 RTL10 AMBRA1 L3MBTL1	1.15e-04	196	217	9	5765_DN
Drug	Lovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	CYLD ZNF219 LRFN3 ZFP36L2 NFIB PLCB3 RALGAPB RGS3 MICALL1	1.15e-04	196	217	9	4978_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	DENND2A ACACB NRXN3 PML RTL10 TBC1D17 THAP7 ARHGAP6 IL4R	1.15e-04	196	217	9	4539_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; HL60; HG-U133A	CYLD ATXN2L TNRC6B FCHO1 SEC24D MICALL1 HIVEP3 KHDRBS1 TNK2	1.15e-04	196	217	9	2015_UP
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A	TNRC6B NOTCH1 AMBRA1 NR1H3 TACC2 RGS3 MICALL1 CDK13 ELK4	1.15e-04	196	217	9	7367_DN
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	BCORL1 CASZ1 ZBED4 FBXO42 MSL3 PLAGL2 USP36 THAP7 ELF4	1.15e-04	196	217	9	7017_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ZNF219 GBF1 PLCB3 USP36 PLEKHA6 MICALL1 TNK2 PCNX1 IL4R	1.15e-04	196	217	9	3251_DN
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ACACB DENND2B PML PRR36 RTL10 RGS3 HIVEP3 PCNX1 IL4R	1.15e-04	196	217	9	3192_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A	CYLD NFIB RHBDD3 DYRK2 AMBRA1 PLEKHA6 NCOR2 ELF4 ELK4	1.15e-04	196	217	9	6323_DN
Drug	Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ACACB BCORL1 ZFP36L2 CASKIN2 PML RTL10 SLC22A18AS ARHGEF40 IRS2	1.15e-04	196	217	9	4970_UP
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	CYLD ZNF219 PML CUX2 TBC1D17 L3MBTL1 ZFHX4 ELK4 MYO15A	1.15e-04	196	217	9	6203_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; PC3; HT_HG-U133A	RB1CC1 NFIB RTL10 THAP7 ARHGAP6 L3MBTL1 CDK13 DNM3 PCNX1	1.20e-04	197	217	9	4231_DN
Drug	CP-863187 [668981-07-5]; Down 200; 10uM; MCF7; HT_HG-U133A	ATXN2L ZBED4 RHBDD3 PLEKHA6 NCOR2 ELF4 ELK4 SRRM2 IL4R	1.20e-04	197	217	9	7553_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HT_HG-U133A	DENND2A FBXO42 RHBDD3 PML MICALL1 NCOR2 L3MBTL1 CDK13 ELF4	1.20e-04	197	217	9	6620_DN
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A	ACACB ZFP36L2 NFIB MSL3 DOK2 RGS3 PITPNM1 ELK4 IL4R	1.20e-04	197	217	9	3629_DN
Drug	rapamycin; Down 200; 0.1uM; HL60; HG-U133A	ATXN2L DENND2A ADM2 APC2 PDZD7 KMT2D AATK TNK2 PCNX1	1.20e-04	197	217	9	362_DN
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A	ZFP36L2 PML DYRK2 PRR36 DOK2 RGS3 TBC1D17 HIVEP3 ARHGEF40	1.20e-04	197	217	9	2819_UP
Disease	hypertension	CASZ1 PLCB3 PRKAG2 NPNT COL6A3 CUX2 NR1H3 BCAR1 GRM5 NCOR2	7.04e-05	307	208	10	EFO_0000537
Disease	cerebral atherosclerosis	NFIB RIN2 SORCS3	1.19e-04	14	208	3	EFO_1000860
Disease	prostate cancer (is_marker_for)	CHAF1B KMT2A ALOX12 HTRA2 KMT2D CDK13 SOS1	1.25e-04	156	208	7	DOID:10283 (is_marker_for)
Disease	Ethylmalonic encephalopathy	TRIM8 TNK2	1.48e-04	3	208	2	C1865349
Disease	Amelogenesis imperfecta	DLX3 ODAPH RELT	2.18e-04	17	208	3	cv:C0002452
Disease	Eosinophilic esophagitis	TRIM8 TNK2	2.94e-04	4	208	2	C0341106
Disease	Autism Spectrum Disorders	NRXN3 TET3 SHANK3 ANKRD11 UNC80	3.44e-04	85	208	5	C1510586
Disease	breast cancer (is_marker_for)	ALOX12 BCAR1 ZFP36 NCOR2 KMT2D L3MBTL1 CDK13	3.56e-04	185	208	7	DOID:1612 (is_marker_for)
Disease	centronuclear myopathy 1 (implicated_via_orthology)	DNM1 DNM3	4.88e-04	5	208	2	DOID:0111223 (implicated_via_orthology)
Disease	microcytic anemia (implicated_via_orthology)	DNM1 DNM3	4.88e-04	5	208	2	DOID:11252 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology)	DNM1 DNM3	4.88e-04	5	208	2	DOID:0110197 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	TNRC6B KMT2A DNM1 HIVEP3 ANKRD11	5.21e-04	93	208	5	C1535926
Disease	alcohol consumption measurement	ATXN2L ACACB ADGRB1 TENM2 NRXN3 MAST4 FBXO42 PLCB3 MGA TET3 RC3H2 CUX2 GRM5 RGS3 MICALL1 NCOR2 ANKRD11 AKAP11 MYO15A RIMS2	5.31e-04	1242	208	20	EFO_0007878
Disease	Clear cell sarcoma of kidney	NUTM2B NUTM2E	7.28e-04	6	208	2	C0334488
Disease	Lennox-Gastaut syndrome	DNM1 CUX2	7.28e-04	6	208	2	C0238111
Disease	autism spectrum disorder (implicated_via_orthology)	NRXN3 SYN1 SHANK1 SCAMP3 SHANK3 RIMS2	7.54e-04	152	208	6	DOID:0060041 (implicated_via_orthology)
Disease	Bilateral Wilms Tumor	BCORL1 MLLT1 COL6A3	1.10e-03	29	208	3	C2930471
Disease	pathological myopia	CLNK PML TACC2 SCML4 ARAP3	1.16e-03	111	208	5	EFO_0004207
Disease	resting heart rate, chronic obstructive pulmonary disease	SYNPO2L CASZ1 WDR20	1.22e-03	30	208	3	EFO_0000341, EFO_0004351
Disease	R-6-hydroxywarfarin measurement	UVSSA GRM5 NCOR2 CTTN SPEN	1.31e-03	114	208	5	EFO_0803327
Disease	Autistic behavior	TET3 CUX2	1.35e-03	8	208	2	C0856975
Disease	triacylglycerol 58:6 measurement	TENM2 HIVEP3	1.35e-03	8	208	2	EFO_0010440
Disease	neutrophil percentage of leukocytes	TNRC6B EPS15L1 PRR14 ZFP36L2 CRTC3 DOK2 SCML4 AATK CDK13 ELF1 AKAP11 TMEM131	1.39e-03	610	208	12	EFO_0007990
Disease	congenital heart disease (implicated_via_orthology)	KMT2A SAP130 USP36 KMT2D	1.45e-03	69	208	4	DOID:1682 (implicated_via_orthology)
Disease	Schizophrenia	RB1CC1 NRXN3 KCNH2 SYN1 KMT2A DNM1 ALOX12 PML SHANK1 AMBRA1 PLEKHA6 GRM5 SHANK3 PITPNM1 RIMS2	1.58e-03	883	208	15	C0036341
Disease	Nephroblastoma	BCORL1 MLLT1 COL6A3	2.08e-03	36	208	3	C0027708
Disease	long QT syndrome (implicated_via_orthology)	KCNH2 ARHGAP6	2.14e-03	10	208	2	DOID:2843 (implicated_via_orthology)
Disease	sexual dimorphism measurement	ATXN2L KCNB2 SPATA31C1 NRXN3 KCNH2 PLCB3 MGA WIPF2 USP36 UVSSA POM121L2 NCOR2 ARHGEF40 KHDRBS1 ANKRD11 DNM3 CD300LG	2.26e-03	1106	208	17	EFO_0021796
Disease	Tinnitus	TNRC6B RB1CC1 FMN1 SORCS3 TMEM131	2.33e-03	130	208	5	HP_0000360
Disease	Macrocephaly	NFIB TET3	2.61e-03	11	208	2	C0221355
Disease	non-melanoma skin carcinoma	IRF3 ZNF469 AMOTL1 GRM5 ZFHX4 ANKRD11 MYO15A	2.85e-03	265	208	7	EFO_0009260
Disease	platelet component distribution width	SRRM1 DENND2A PRRC2C RIN2 DNM1 WEE1 DOK2 RFX2 MICALL1 BCL6B NCOR2 DNM3 IRS2	2.86e-03	755	208	13	EFO_0007984
Disease	cognitive function measurement	LVRN ATXN2L IRF2BP2 GBF1 FAM161B NRXN3 MAST4 NFIB FMN1 PRRC2C PRKAG2 CLNK POM121L2 RGS3 SHANK3 KMT2D ARAP3 SORCS3 TMEM131 SOS1	2.93e-03	1434	208	20	EFO_0008354
Disease	mean arterial pressure	SYNPO2L CASZ1 PLEKHA7 NPNT USP36 CUX2 BCAR1 POM121C HIVEP3 ARAP3	3.01e-03	499	208	10	EFO_0006340
Disease	epilepsy	GBF1 MAST4 CUX2	3.02e-03	41	208	3	EFO_0000474
Disease	colorectal health	XIRP1 KCNB2 NRXN3 LUZP2 PITPNM3 SORCS3	3.11e-03	201	208	6	EFO_0008460
Disease	collagen disease (implicated_via_orthology)	DNM1 DNM3	3.12e-03	12	208	2	DOID:854 (implicated_via_orthology)
Disease	intraocular pressure measurement	ZNF469 ZFP36L2 KMT2A PRKAG2 PLEKHA7 COL6A3 RTL10 NR1H3 HIVEP3 NALF2	3.46e-03	509	208	10	EFO_0004695
Disease	Sclerocystic Ovaries	TNRC6B ARHGAP30 ERRFI1 LTK HACD1	3.62e-03	144	208	5	C1136382
Disease	Polycystic Ovary Syndrome	TNRC6B ARHGAP30 ERRFI1 LTK HACD1	3.62e-03	144	208	5	C0032460
Disease	phosphocreatine measurement	TENM2 RIN2	3.66e-03	13	208	2	EFO_0010521
Disease	Connective Tissue Diseases	ZNF469 NOTCH1	3.66e-03	13	208	2	C0009782
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	DNM1 DNM3	3.66e-03	13	208	2	DOID:0112202 (implicated_via_orthology)
Disease	response to beta blocker	LUZP2 BCAR1 GRM5	3.94e-03	45	208	3	EFO_0007766
Disease	red blood cell density measurement	IRF2BP2 SRRM1 ZNF219 TNRC6B DENND2B CASZ1 FMN1 PLCB3 PRKAG2 RGS3 ARHGEF40 DNM3 IRS2 MYO15A	4.04e-03	880	208	14	EFO_0007978
Disease	eosinophil count	CHAF1B EPS15L1 ZFP36L2 PLCB3 WIPF2 TET3 NOTCH1 TCEA2 CRTC3 CUX2 DOK2 HIVEP3 NCOR2 ANKRD11 CD300LG ELF1 PCNX1 TNKS1BP1 TMEM131 IL4R	4.43e-03	1488	208	20	EFO_0004842
Disease	albuminuria	FMN1 PRRC2C PRKAG2 LTK	4.46e-03	94	208	4	EFO_0004285
Disease	pulse pressure measurement	SYNPO2L TNRC6B CASZ1 TRIM8 PRKAG2 PLEKHA7 HOMEZ NPNT USP36 TCEA2 COL6A3 RC3H2 CUX2 BCAR1 HIVEP3 ZFHX4 ANKRD11 PITPNM3 SORCS3	4.68e-03	1392	208	19	EFO_0005763
Disease	atrial fibrillation	SYNPO2L CASZ1 KCNH2 CRAMP1 CUX2 NCOR2 ZFHX4 SPEN	5.01e-03	371	208	8	EFO_0000275
Disease	Adenoid Cystic Carcinoma	BCORL1 NFIB MGA NOTCH1	5.55e-03	100	208	4	C0010606
Disease	T-Cell Lymphoma	MGA KMT2D	5.56e-03	16	208	2	C0079772
Disease	central nervous system disease (implicated_via_orthology)	IRF2BP2 SEC31B	5.56e-03	16	208	2	DOID:331 (implicated_via_orthology)
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	NOTCH1 EIF4EBP1	5.56e-03	16	208	2	C0334634
Disease	Early infantile epileptic encephalopathy with suppression bursts	TRIM8 DNM1	5.56e-03	16	208	2	C0393706
Disease	Vitiligo	IRF3 PTPN22 PLCB3 CLNK	5.75e-03	101	208	4	EFO_0004208
Disease	corpus callosum posterior volume measurement	TNRC6B GAREM1 SOS1	5.92e-03	52	208	3	EFO_0010298
Disease	household income	GBF1 MAST4 NFIB LUZP2 WIPF2 ARAP3 PCNX1	6.00e-03	304	208	7	EFO_0009695
Disease	age at first sexual intercourse measurement	IRF2BP2 BCORL1 KCNB2 SMC5 TENM2 AMBRA1 AATK SORCS3	6.03e-03	383	208	8	EFO_0009749
Disease	Small cell carcinoma of lung	KMT2A KIF21A RIMS2	6.58e-03	54	208	3	C0149925
Disease	telomere length	KCNB2 NRXN3 CLNK PITPNM1 HIVEP3 SORCS3 UNC80	6.99e-03	313	208	7	EFO_0004505

Protein segments in the cluster

Peptide	Gene	Start	Entry
QPRPPPRPTTSLLLE	ALKBH6	151	Q3KRA9
PREPPARSPSSSLQP	ADM2	36	Q7Z4H4
LPASPPPKDSLRSTP	EPS15L1	226	Q9UBC2
PSSFQSPTRPPLASP	PRKAG2	206	Q9UGJ0
PESPQTSSRPPLAPL	ADAD2	186	Q8NCV1
KPPRPDSPATTPNIS	ELF1	181	P32519
PPRPSSCLLIPSPEN	nan	251	Q9N2K0
SLLLPSSPGPRPAPS	ARHGEF40	991	Q8TER5
PSPRPPPLPTSSSEQ	ARAP3	131	Q8WWN8
EPPALPPDQASTRLP	ANKRD11	2186	Q6UB99
PARTPLVLAAPPPDS	BCAR1	341	P56945
ASLPARSPPSRQPPS	ADGRB1	1386	O14514
PTPSLAPAPLASVPS	CASZ1	391	Q86V15
PPRDLPTIPGVTSPS	EIF4EBP1	71	Q13541
LPTPQPLLPAPSGSS	BCORL1	561	Q5H9F3
APTPVPRLSESANPP	RTL10	296	Q7L3V2
PAPTVIRDPPSITPA	CHAF1B	441	Q13112
VIPDTPPSTPLVPSR	AKAP11	1096	Q9UKA4
ASAPLLPPPPTSALS	AMOTL1	841	Q8IY63
LTTPDSGLPRPPNPA	SLC22A18AS	211	Q8N1D0
AESSPPLRQKPTPTP	LVRN	56	Q6Q4G3
REPTQPTLPSSSPVP	AMBRA1	1241	Q9C0C7
RSVPPSPPERPSLAT	CUX2	721	O14529
SRSQSVSPPPVLSPP	DENND2B	26	P78524
HSTPAPARSQLPPPL	DLX3	221	O60479
LQLRPPPEPSTPVSG	CDK13	1216	Q14004
PSSSPENSLDPFPPR	ATXN2L	556	Q8WWM7
DETPPQSPTRALPRP	TNK2	601	Q07912
ATAPALPQPPSTPRA	CCDC80	336	Q76M96
RQLTPLPPSAPPSAD	NPIPB3	391	Q92617
SERQLTPLPPSAPPS	NPIPB3	431	Q92617
TPLPPSAPPSADDNI	NPIPB3	436	Q92617
TPSERQLTPLPPSAP	NPIPB3	471	Q92617
QLTPLPPSAPPSADD	NPIPB3	476	Q92617
TPSERQLTPLPPSAP	NPIPB3	551	Q92617
QLTPLPPSAPPSADD	NPIPB3	556	Q92617
TPSERQLTPLPPSAP	NPIPB3	801	Q92617
QLTPLPPSAPPSADD	NPIPB3	806	Q92617
ERQLTPLPPSAPPSA	NPIPB3	846	Q92617
ACQPPSEPRTTVPLP	RC3H2	746	Q9HBD1
LPFPTQAILPPAPSS	NFIB	366	O00712
SPTRDLPPCQDLPPS	RGS3	806	P49796
QTSPVPSPLSPRLPS	FMN1	516	Q68DA7
SSPPPPLPERTLESF	PTPN22	691	Q9Y2R2
RQLTPLPPSAPPSAD	NPIPB12	391	F8W0I5
SERQLTPLPPSAPPS	NPIPB12	431	F8W0I5
TPLPPSAPPSADDNI	NPIPB12	436	F8W0I5
SERQLTPLPPSAPPS	NPIPB12	681	F8W0I5
TPLPPSAPPSADDNI	NPIPB12	686	F8W0I5
TPSERQLTPLPPSAP	NPIPB12	721	F8W0I5
QLTPLPPSAPPSADD	NPIPB12	726	F8W0I5
ERQLTPLPPSAPPSA	NPIPB12	766	F8W0I5
SLPPRASSPPQILPQ	NR1H3	191	Q13133
SLPPSHQKPPRNPLS	ACACB	91	O00763
TSPRTPPPLTVQDPL	RB1CC1	666	Q8TDY2
RAPPLPDSPQPLASS	FCHO1	516	O14526
PSLNSRPSPISATPP	FBXO42	366	Q6P3S6
RPSPISATPPALVPE	FBXO42	371	Q6P3S6
PHLRPLPESQPSSSP	NCOR2	2101	Q9Y618
RRPNTATPSPIPSPT	NOL9	76	Q5SY16
ALLSRPAPAPSPAPT	RENBP	406	P51606
QPATIPASLPRPDSP	DOK2	256	O60496
SPALPTSLPSSLVPP	NOTCH1	2461	P46531
TPQNPSSLAPAPLRP	GPSM3	86	Q9Y4H4
PAPARPRSPSPISTL	GRM5	1011	P41594
PSSPGAPLLSNLPRP	MAP1A	2236	P78559
PRRSPSTPAPSESLP	H2BC20P	116	Q6DN03
PRRSPSTPAPSESLP	H2BC19P	116	Q6DRA6
RLPAPSKPSETPPSS	MGA	1841	Q8IWI9
PLPPTTPERPTTGLT	NPNT	341	Q6UXI9
METSSPRPPRPSSNP	NTSR2	1	O95665
PLAPPSPQLSLRTGP	MYO15A	791	Q9UKN7
PSLLGNQTLSPPSRP	ELF4	591	Q99607
TSSPTPQRRAPAVPP	DNM1	776	Q05193
PLPSVSPALSPVRSP	ESPN	691	B1AK53
SPALSPVRSPTPPAA	ESPN	696	B1AK53
LSSLPQSLPAPAPSP	MCM3AP	1026	O60318
PAPTPSLLNIPLSSP	KCNH2	1016	Q12809
IQEPPSRIVPTPTSP	DAG1	331	Q14118
SRIVPTPTSPAIAPP	DAG1	336	Q14118
RSPSLALSPPPALAP	C9orf131	556	Q5VYM1
PPSPTTQRRPTLSAP	DNM3	771	Q9UQ16
PPSPTRPTIIRPLES	DNM3	851	Q9UQ16
SSPLPLASPSPRDPK	LTK	31	P29376
SNPTPPTLLIGSPLS	PCNX1	801	Q96RV3
PLQPPLGPREPSSAS	L3MBTL1	581	Q9Y468
PTDARLLQPTPSPAP	PDZD7	1001	Q9H5P4
PPSPLTPPDLNLRAE	FAM217B	106	Q9NTX9
NAPPVPPRSAKPLST	GAREM1	531	Q9H706
EELSPSPPLLNPSTP	MSL3	306	Q8N5Y2
TPPIATRAPSITLPP	NRXN3	1351	Q9Y4C0
RTPTLASTPIPPTPQ	NES	381	P48681
PVPPPRSTSRNFPSS	KIAA0408	266	Q6ZU52
SPQPPATPLPRSRSL	FAM161B	426	Q96MY7
RQLTPLPPSAPPSAD	NPIPB5	391	A8MRT5
SERQLTPLPPSAPPS	NPIPB5	431	A8MRT5
TPLPPSAPPSADDNI	NPIPB5	436	A8MRT5
TPSERQLTPLPPSAP	NPIPB5	471	A8MRT5
QLTPLPPSAPPSADD	NPIPB5	476	A8MRT5
TPSERQLTPLPPSAP	NPIPB5	551	A8MRT5
QLTPLPPSAPPSADD	NPIPB5	556	A8MRT5
SERQLTPLPPSAPPS	NPIPB5	886	A8MRT5
TPLPPSAPPSADDNI	NPIPB5	891	A8MRT5
TPSERQLTPLPPSAP	NPIPB5	926	A8MRT5
QLTPLPPSAPPSADD	NPIPB5	931	A8MRT5
ERQLTPLPPSAPPSA	NPIPB5	971	A8MRT5
STTPAPPTPRPRSSL	MICALL1	311	Q8N3F8
EPPPPGTSSQIRSPL	GARIN5A	11	Q6IPT2
TPAPPLRPPDSLSRA	NALF2	161	O75949
LPLAPASSPPQSATP	LRFN3	11	Q9BTN0
TVPRAPSQFPPPLET	GGN	156	Q86UU5
PNPSSPTPTLFLPSD	ALOX12	321	P18054
RQLTPLPPSAPPSAD	NPIPB4	391	C9JG80
SERQLTPLPPSAPPS	NPIPB4	431	C9JG80
TPLPPSAPPSADDNI	NPIPB4	436	C9JG80
TPSERQLTPLPPSAP	NPIPB4	471	C9JG80
QLTPLPPSAPPSADD	NPIPB4	476	C9JG80
ERQLTPLPPSAPPSA	NPIPB4	516	C9JG80
RQLTPLPPSAPPSAD	NPIPB4	601	C9JG80
SERQLTPLPPSAPPS	NPIPB4	891	C9JG80
TPLPPSAPPSADDNI	NPIPB4	896	C9JG80
TPSERQLTPLPPSAP	NPIPB4	931	C9JG80
QLTPLPPSAPPSADD	NPIPB4	936	C9JG80
ERQLTPLPPSAPPSA	NPIPB4	976	C9JG80
EPLPLPPARSPSQES	CASKIN2	686	Q8WXE0
PPASSLPQPEPSSLP	CASKIN2	1031	Q8WXE0
LPAPIPTLLSNSPPS	FOXB1	276	Q99853
PSLPTPLLRPSGRPS	POM121C	176	A8CG34
PASPPTSLLAPSTNP	POM121B	166	A6NF01
SERQLTPLPPSAPPS	NPIPB11	351	E5RHQ5
TPLPPSAPPSADDNI	NPIPB11	356	E5RHQ5
TPSERQLTPLPPSAP	NPIPB11	391	E5RHQ5
QLTPLPPSAPPSADD	NPIPB11	396	E5RHQ5
ERQLTPLPPSAPPSA	NPIPB11	436	E5RHQ5
RQLTPLPPSAPPSAD	NPIPB11	521	E5RHQ5
SERQLTPLPPSAPPS	NPIPB11	561	E5RHQ5
TPLPPSAPPSADDNI	NPIPB11	566	E5RHQ5
TPLPPSAPPSADDNI	NPIPB11	906	E5RHQ5
QLTPLPPSAPPSADD	NPIPB11	946	E5RHQ5
ERQLTPLPPSAPPSA	NPIPB11	986	E5RHQ5
PSERQLTPLPPSAPT	NPIPB11	1026	E5RHQ5
PNESTSPNTPEPAPR	ARHGAP6	341	O43182
NHSPPTPRRSPLPID	RIMS2	461	Q9UQ26
SNPTPSPLDASPRRP	PLCB3	906	Q01970
PLPPRPSASPSSSLQ	IRS2	1016	Q9Y4H2
FTLTPPPAPRSPVTR	ODAPH	46	Q17RF5
LPSPSRLPGPSDTPI	CGB2	146	Q6NT52
ASPPPLLLPRSHSDP	FAM189B	481	P81408
PAAPPPARTQPSLIA	APC2	1556	O95996
VLAAVPSPPPASPRS	HTRA2	131	O43464
RSSPPTTPLRAPDPS	IL4R	751	P24394
APQTPPSTARPLPVT	KCNB2	726	Q92953
SLRPLEAEPPTPPTA	BCL6B	141	Q8N143
SSLSSSQPPEPLRPL	C5orf60	231	A6NFR6
PLPSSPPPSSVNRRL	DENND2A	306	Q9ULE3
LQEPPRTPSPPLSSH	ELK4	261	P28324
LPPPSSQPLPSTHRD	FAM193B	346	Q96PV7
TASPSPLAPDPPRII	C21orf58	186	P58505
RQPPVSPLTLSPGPE	CRTC3	386	Q6UUV7
GSPPTLLPLSPTSPR	HACD1	21	B0YJ81
PPPPQPARSASSSTI	COL6A3	3081	P12111
LSLSSPDAPDRPPPR	CRAMP1	501	Q96RY5
PARPTVPSSQRLPEP	CC2D1B	506	Q5T0F9
LASPLASAPPQRPPS	CARD19	141	Q96LW7
DTRSINPARPLPTPP	CEACAM19	256	Q7Z692
RNFPIPIPESAPTTP	FDCSP	66	Q8NFU4
QPPPPLSLITSNPTR	LUZP2	221	Q86TE4
LEPTPTGSLTPRPPR	IFRD2	46	Q12894
LSPLARTPSPTPQPT	MAST4	1376	O15021
TPQPTSPQRSPSPLL	MAST4	1386	O15021
LPLQPPSRPCSPSDQ	IL22RA1	511	Q8N6P7
PKTPVSSLRPEPPET	FAM47A	216	Q5JRC9
SRLSPTPDGPPPLAQ	GBF1	1791	Q92538
PAPTPLLPPSATASV	KHDRBS1	81	Q07666
TQTVELPCPPPSPRL	KLHDC4	51	Q8TBB5
LPCPPPSPRLNASLS	KLHDC4	56	Q8TBB5
LTPPPPLQPASSISD	KMT2A	566	Q03164
IISPPSPDRPPHSQT	KMT2A	2116	Q03164
PSPQLRVTSAPPPTS	C2orf81	181	A6NN90
NPEPSSPPSPLFLEA	ARRDC1-AS1	66	Q9H2J1
PSVVTRPEPQALPSP	DDX17	51	Q92841
QDPAIPTPPPSTRSL	HOMEZ	431	Q8IX15
SPDLAPTPAPQSTPR	EIF2A	506	Q9BY44
NSADSSLPSREPPPP	MLLT1	446	Q03111
PSQSPRPSPSEVLPT	CELSR3	2366	Q9NYQ7
RTRDLDPQPPPLPLS	CELSR3	3161	Q9NYQ7
DRSSPPLQPPPVNSL	CYLD	396	Q9NQC7
PPRDLSPSARPISSP	RTL8C	186	O15255
LPPPSAPSLQPSRKL	SCAMP3	61	O14828
PPSPIALPPLRASNA	DYRK2	46	Q92630
SRPAASLAQPPTPQP	IRF2BP2	136	Q7Z5L9
ARPSPPVQSVSPAVP	PPRC1	856	Q5VV67
SRPISDPSSLLAPPP	CCDC24	61	Q8N4L8
RQLTPLPPSAPPSAD	NPIPB13	391	A6NJU9
SERQLTPLPPSAPPS	NPIPB13	431	A6NJU9
TPLPPSAPPSADDNI	NPIPB13	436	A6NJU9
TPSERQLTPLPPSAP	NPIPB13	471	A6NJU9
QLTPLPPSAPPSADD	NPIPB13	476	A6NJU9
ERQLTPLPPSAPPSA	NPIPB13	516	A6NJU9
ERQLTPLPPSAPPSA	NPIPB13	766	A6NJU9
RQLTPLPPSAPPSAD	NPIPB13	851	A6NJU9
SERQLTPLPPSAPPS	NPIPB13	891	A6NJU9
TPLPPSAPPSADDNI	NPIPB13	896	A6NJU9
TPSERQLTPLPPSAP	NPIPB13	931	A6NJU9
QLTPLPPSAPPSADD	NPIPB13	936	A6NJU9
ERQLTPLPPSAPPSA	NPIPB13	976	A6NJU9
GPSSPRPSPLLPESL	ARHGAP30	346	Q7Z6I6
PPQPSLTASPSSRPV	OTOG	1646	Q6ZRI0
PSPTPLSRNNLLPPI	FAM149B1	461	Q96BN6
PCPQPLRSPSLDNPT	IRF3	166	Q14653
RTSPTPNSCPLPLPL	NUTM2B	51	A6NNL0
RTSPTPNSCPLPLPL	NUTM2E	51	B1AL46
RTELASAPVPSPAPP	SYNPO2L	921	Q9H987
GSPLPQRLPSPTSAP	SYN1	501	P17600
PSDTDPEPRTLNPSP	STK11IP	391	Q8N1F8
SEPRPPISSPRAPQT	RAB11FIP1	521	Q6WKZ4
LPPPSSASPSRALPE	UVSSA	471	Q2YD98
RTRSTQKPVSPPPPL	THAP8	96	Q8NA92
RSSTGPEPPAPTPLL	SRRM2	356	Q9UQ35
PPRVKSSTPPRQSPS	SRRM2	896	Q9UQ35
GPRLPLPSVPSPSQE	AATK	791	Q6ZMQ8
LRPSAAAPPVPASPQ	RFX2	16	P48378
PAAPASRPPALSPLS	SORCS3	46	Q9UPU3
TPSRGPPQLSSPPAL	PIWIL2	176	Q8TC59
SPPALPQSPLHSPDR	PIWIL2	186	Q8TC59
PPIATRAPSITLPPT	NRXN3	346	Q9HDB5
PEQPRPSTSKAVSPP	PML	506	P29590
DNAATPLPATLPPSP	PRR36	321	Q9H6K5
SPSAPPSLQTLPSPP	PRR36	376	Q9H6K5
PSLQTLPSPPATPPS	PRR36	381	Q9H6K5
PDSPPLQAPLSLPAS	PRR36	651	Q9H6K5
APPPLQTASAPLTTP	PRR36	741	Q9H6K5
PSLAPPPLQTASAPL	PRR36	761	Q9H6K5
ELPSTPPPSSLLRPR	PRR14	226	Q9BWN1
PSPPTSPVRTPLEVR	PLEKHA7	866	Q6IQ23
VPPLASAPLPPSTSA	PRRC2C	1746	Q9Y520
SQAPSPLLSSDLPPP	SPATA32	221	Q96LK8
ENGRPIPPTSSPSLL	TENM2	166	Q9NT68
PRPIPLSSSTPGLPS	PRR32	226	B1ATL7
PPPLPRSNSLPHSAV	WDR20	426	Q8TBZ3
APPVLNPPSTRSSFP	RNF217	191	Q8TC41
PSLLQPPPPAASSTS	TSC22D1	61	Q15714
PTPSPRPRVFTPQSS	SEC31B	826	Q9NQW1
SQPPEPSLLLERPSP	SPATA31C1	196	P0DKV0
AATREPPSLQPPPAL	TEX45	51	Q8NA69
TASAPNSPRTPLTPP	SOS1	1076	Q07889
RTSISDPPESPPLLP	SOS1	1201	Q07889
PREPLSPSNSRTPSP	ERRFI1	321	Q9UJM3
RITPPDQRVPPSTSP	POM121L2	121	Q96KW2
PLESSPISSPAQLPP	PLAGL2	326	Q9UPG8
PLSATSLQTPPRPPQ	SEC24D	146	O94855
PETSPPFPDLSAQLP	STXBP5L	571	Q9Y2K9
VSPAPRPSSLPILPS	SHANK1	2011	Q9Y566
SPERQPSPLEPRPVS	THAP7	196	Q9BT49
PPSPSPTFQPLATTR	CD300LG	131	Q6UXG3
LPPEPESSRPPLSQR	CLNK	176	Q7Z7G1
PSPLRGNVVPSPLPT	CARHSP1	31	Q9Y2V2
RVSLFIPPQTPPETP	CLCA1	861	A8K7I4
EDSALPPPSLRPVQP	RHBDD3	251	Q9Y3P4
DSNIPPPSLKTRPPS	XIRP2	2931	A4UGR9
SPEPSALPPQRIPSD	PITPNM1	621	O00562
RSLQLPASPAPDPSP	PLEKHA6	841	Q9Y2H5
PPPPAINSLHTSPRL	RIN2	311	Q8WYP3
TASPLPLSPTRAPPT	TBC1D17	606	Q9HA65
RPPSASQTPVPSSPL	ZFHX4	2416	Q86UP3
QEPDSPLPPARSPTE	WEE1	56	P30291
PSPSPRQASPVAPLL	nan	6	Q6ZSR3
PEPDIPLLPRPRSSS	UNC80	371	Q8N2C7
EEPRAQSTPSPALPP	SPEN	2506	Q96T58
RAPPPPKRAPSTTLT	SHANK3	676	Q9BYB0
SARSRSPSPSPLPSP	SHANK3	1631	Q9BYB0
TPPVSPAPQPTEERL	CTTN	401	Q14247
PAPQPTEERLPSSPV	CTTN	406	Q14247
SPPSSPPSRPRNELN	KIF21A	1271	Q7Z4S6
SPTPSPSPPRNSDQE	SRRM1	791	Q8IYB3
KAPASPRRPQTPTPS	ZSCAN1	6	Q8NBB4
SRPIAPAPPSTLSLP	SAP130	151	Q9H0E3
RPSSPPPEVLEPHSL	TNKS1BP1	366	Q9C0C2
PQPERLSPAPLAHPS	TMEM131	1316	Q92545
PRLGPELSPSPTSPT	ZFP36	81	P26651
RLPPVAPPASSSAPT	HIVEP3	1286	Q5T1R4
RAPTNPEPSATPPLD	HIVEP3	2336	Q5T1R4
TRLPSPTPRLPTSSP	VWCE	316	Q96DN2
SAPDPPRPRPVSLSL	SMTNL2	176	Q2TAL5
LDNTPASPPRSPAEP	TACC2	2311	O95359
SPKRSPLSDPPSQDP	TACC2	2436	O95359
RSDLFLPPSPESPPN	TESK1	356	Q15569
PAPSPVLQREAPTPS	TET3	501	O43151
SPNQTSSEPRPLPAP	RALGAPB	421	Q86X10
PPLLDAPASPPQASR	PITPNM3	496	Q9BZ71
PTPSPPSPNRESLAL	ZNF469	2026	Q96JG9
SSSQPPEPLRPLECP	nan	61	Q8NA96
TTPVPSLLPNPTRVP	RELT	316	Q969Z4
QRPPISIAPSSPLLP	USP24	2366	Q9UPU5
SLPSTTRPHLPPTPQ	LINC01356	76	Q8N9X3
LPRAPSTPRITTFPP	TCEA2	116	Q15560
LTPPHSPPPSSRQLL	PLEKHG2	1256	Q9H7P9
PEQPPLIPSRDSESP	TXLNB	541	Q8N3L3
PPPPTSASPSLLSNR	WIPF2	296	Q8TF74
SASPSLLSNRPPPPA	WIPF2	301	Q8TF74
SGPITTPPLRSTPRP	ABI3BP	731	Q7Z7G0
TPPLRSTPRPTGTPL	ABI3BP	736	Q7Z7G0
PSPQPSKRALPRDPS	SMC5	11	Q8IY18
LPPTPSVPQSLPSLA	TRIM8	506	Q9BZR9
SPLLLDSPTSRTPPP	ZFP36L2	276	P47974
PPRVLPSSRDSPSSP	XIRP1	1656	Q702N8
PPRSTPEPDLSSIPQ	SCML4	66	Q8N228
ERPLAATSAAPPPQP	ZNF219	216	Q9P2Y4
DLRPPPPSPSSDLTH	USP36	706	Q9P275
SSPPPLQNRKSPSPL	ZNF683	156	Q8IZ20
SSRNTTPLPRPPPGL	TNRC6B	1591	Q9UPQ9
AGQPPPSSLRSLVPP	ZNF541	246	Q9H0D2
DPSAPTPTPTSPLLN	THPO	326	P40225
SFPSPSLLLPPQPAD	ZBED4	181	O75132
PSSPQEPKRPSQLPS	KMT2D	4311	O14686